sp|P41587|VIPR2_HUMAN,sp|P41587|VIPR2_HUMAN,100.000,438,0,0,1,438,1,438,0.0,899,P41587,Vasoactive intestinal polypeptide receptor 2 OS=Homo sapiens OX=9606 GN=VIPR2 PE=1 SV=2
sp|P41587|VIPR2_HUMAN,tr|G3QWR4|G3QWR4_GORGO,99.543,438,2,0,1,438,1,438,0.0,895,G3QWR4,Uncharacterized protein OS=Gorilla gorilla gorilla OX=9595 PE=3 SV=2
sp|P41587|VIPR2_HUMAN,tr|A0A2R8ZUP0|A0A2R8ZUP0_PANPA,99.540,435,2,0,4,438,1,435,0.0,890,A0A2R8ZUP0,Vasoactive intestinal peptide receptor 2 OS=Pan paniscus OX=9597 GN=VIPR2 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A2K5X117|A0A2K5X117_MACFA,97.945,438,9,0,1,438,27,464,0.0,882,A0A2K5X117,Vasoactive intestinal peptide receptor 2 OS=Macaca fascicularis OX=9541 GN=VIPR2 PE=3 SV=2
sp|P41587|VIPR2_HUMAN,tr|A0A1D5Q8N3|A0A1D5Q8N3_MACMU,97.489,438,11,0,1,438,1,438,0.0,879,A0A1D5Q8N3,Vasoactive intestinal peptide receptor 2 OS=Macaca mulatta OX=9544 GN=VIPR2 PE=3 SV=2
sp|P41587|VIPR2_HUMAN,tr|F6XPH6|F6XPH6_CALJA,97.032,438,13,0,1,438,1,438,0.0,875,F6XPH6,Vasoactive intestinal polypeptide receptor 2 OS=Callithrix jacchus OX=9483 GN=VIPR2 PE=2 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A2K6S2S4|A0A2K6S2S4_SAIBB,97.032,438,13,0,1,438,1,438,0.0,874,A0A2K6S2S4,Vasoactive intestinal peptide receptor 2 OS=Saimiri boliviensis boliviensis OX=39432 GN=VIPR2 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A2K6MRQ1|A0A2K6MRQ1_RHIBE,97.260,438,12,0,1,438,1,438,0.0,874,A0A2K6MRQ1,Uncharacterized protein OS=Rhinopithecus bieti OX=61621 GN=VIPR2 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A6J3F5K3|A0A6J3F5K3_SAPAP,96.575,438,15,0,1,438,1,438,0.0,871,A0A6J3F5K3,vasoactive intestinal polypeptide receptor 2 isoform X2 OS=Sapajus apella OX=9515 GN=VIPR2 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A2K5Q2Q9|A0A2K5Q2Q9_CEBIM,96.575,438,15,0,1,438,1,438,0.0,871,A0A2K5Q2Q9,Vasoactive intestinal peptide receptor 2 OS=Cebus imitator OX=2715852 GN=VIPR2 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A2K6CQB8|A0A2K6CQB8_MACNE,98.135,429,8,0,1,429,11,439,0.0,863,A0A2K6CQB8,Vasoactive intestinal peptide receptor 2 OS=Macaca nemestrina OX=9545 GN=VIPR2 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|C9JCP7|C9JCP7_HUMAN,100.000,421,0,0,18,438,159,579,0.0,863,C9JCP7,Vasoactive intestinal polypeptide receptor 2 OS=Homo sapiens OX=9606 GN=VIPR2 PE=1 SV=1
sp|P41587|VIPR2_HUMAN,tr|C9JCP7|C9JCP7_HUMAN,90.000,20,2,0,1,20,1,20,1.2,41.2,C9JCP7,Vasoactive intestinal polypeptide receptor 2 OS=Homo sapiens OX=9606 GN=VIPR2 PE=1 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A2R8ZTG4|A0A2R8ZTG4_PANPA,99.525,421,2,0,18,438,155,575,0.0,860,A0A2R8ZTG4,Vasoactive intestinal peptide receptor 2 OS=Pan paniscus OX=9597 GN=VIPR2 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A2I2Z359|A0A2I2Z359_GORGO,96.804,438,12,1,1,438,117,552,0.0,860,A0A2I2Z359,Uncharacterized protein OS=Gorilla gorilla gorilla OX=9595 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A2I2Z359|A0A2I2Z359_GORGO,90.000,20,2,0,1,20,1,20,1.2,41.2,A0A2I2Z359,Uncharacterized protein OS=Gorilla gorilla gorilla OX=9595 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|H2QVP2|H2QVP2_PANTR,99.525,421,2,0,18,438,159,579,0.0,860,H2QVP2,Vasoactive intestinal peptide receptor 2 OS=Pan troglodytes OX=9598 GN=VIPR2 PE=3 SV=2
sp|P41587|VIPR2_HUMAN,tr|H2QVP2|H2QVP2_PANTR,90.000,20,2,0,1,20,1,20,1.2,41.2,H2QVP2,Vasoactive intestinal peptide receptor 2 OS=Pan troglodytes OX=9598 GN=VIPR2 PE=3 SV=2
sp|P41587|VIPR2_HUMAN,tr|H2PP71|H2PP71_PONAB,98.575,421,5,1,18,438,1,420,0.0,851,H2PP71,Vasoactive intestinal peptide receptor 2 OS=Pongo abelii OX=9601 GN=VIPR2 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A2K6PAZ2|A0A2K6PAZ2_RHIRO,97.176,425,12,0,14,438,88,512,0.0,850,A0A2K6PAZ2,Vasoactive intestinal peptide receptor 2 OS=Rhinopithecus roxellana OX=61622 GN=VIPR2 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|G1QMW7|G1QMW7_NOMLE,98.337,421,7,0,18,438,110,530,0.0,849,G1QMW7,Uncharacterized protein OS=Nomascus leucogenys OX=61853 GN=VIPR2 PE=3 SV=2
sp|P41587|VIPR2_HUMAN,tr|F7A537|F7A537_MACMU,97.387,421,11,0,18,438,3,423,0.0,846,F7A537,Vasoactive intestinal peptide receptor 2 OS=Macaca mulatta OX=9544 GN=VIPR2 PE=3 SV=3
sp|P41587|VIPR2_HUMAN,tr|A0A2K5P3F2|A0A2K5P3F2_CERAT,97.862,421,9,0,18,438,160,580,0.0,845,A0A2K5P3F2,Vasoactive intestinal peptide receptor 2 OS=Cercocebus atys OX=9531 GN=VIPR2 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A2K5P3F2|A0A2K5P3F2_CERAT,90.000,20,2,0,1,20,1,20,1.2,41.2,A0A2K5P3F2,Vasoactive intestinal peptide receptor 2 OS=Cercocebus atys OX=9531 GN=VIPR2 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A2K5Y2D1|A0A2K5Y2D1_MANLE,97.176,425,12,0,14,438,13,437,0.0,845,A0A2K5Y2D1,Vasoactive intestinal peptide receptor 2 OS=Mandrillus leucophaeus OX=9568 GN=VIPR2 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A0D9R247|A0A0D9R247_CHLSB,95.890,438,18,0,1,438,1,438,0.0,843,A0A0D9R247,Uncharacterized protein OS=Chlorocebus sabaeus OX=60711 GN=VIPR2 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A1D5RG42|A0A1D5RG42_MACMU,94.292,438,11,1,1,438,1,424,0.0,843,A0A1D5RG42,Vasoactive intestinal peptide receptor 2 OS=Macaca mulatta OX=9544 GN=VIPR2 PE=3 SV=2
sp|P41587|VIPR2_HUMAN,tr|A0A2K6MRS0|A0A2K6MRS0_RHIBE,96.698,424,14,0,15,438,55,478,0.0,842,A0A2K6MRS0,Uncharacterized protein OS=Rhinopithecus bieti OX=61621 GN=VIPR2 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A2I3N0J8|A0A2I3N0J8_PAPAN,95.814,430,18,0,9,438,107,536,0.0,841,A0A2I3N0J8,Vasoactive intestinal peptide receptor 2 OS=Papio anubis OX=9555 GN=VIPR2 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A2I3MW26|A0A2I3MW26_PAPAN,97.387,421,11,0,18,438,3,423,0.0,841,A0A2I3MW26,Vasoactive intestinal peptide receptor 2 OS=Papio anubis OX=9555 GN=VIPR2 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A2K5Y2C6|A0A2K5Y2C6_MANLE,97.625,421,10,0,18,438,79,499,0.0,840,A0A2K5Y2C6,Vasoactive intestinal peptide receptor 2 OS=Mandrillus leucophaeus OX=9568 GN=VIPR2 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A6J3F597|A0A6J3F597_SAPAP,96.454,423,15,0,16,438,20,442,0.0,839,A0A6J3F597,vasoactive intestinal polypeptide receptor 2 isoform X1 OS=Sapajus apella OX=9515 GN=VIPR2 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A2K6PB02|A0A2K6PB02_RHIRO,97.150,421,12,0,18,438,133,553,0.0,839,A0A2K6PB02,Vasoactive intestinal peptide receptor 2 OS=Rhinopithecus roxellana OX=61622 GN=VIPR2 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A2K6MRS7|A0A2K6MRS7_RHIBE,97.150,421,12,0,18,438,146,566,0.0,839,A0A2K6MRS7,Uncharacterized protein OS=Rhinopithecus bieti OX=61621 GN=VIPR2 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A2K6MRS7|A0A2K6MRS7_RHIBE,90.000,20,2,0,1,20,1,20,1.3,41.2,A0A2K6MRS7,Uncharacterized protein OS=Rhinopithecus bieti OX=61621 GN=VIPR2 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A2K5Q2Q5|A0A2K5Q2Q5_CEBIM,96.675,421,14,0,18,438,130,550,0.0,837,A0A2K5Q2Q5,Vasoactive intestinal peptide receptor 2 OS=Cebus imitator OX=2715852 GN=VIPR2 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A2K5Q2Q5|A0A2K5Q2Q5_CEBIM,40.000,70,35,2,1,68,1,65,2.2,40.4,A0A2K5Q2Q5,Vasoactive intestinal peptide receptor 2 OS=Cebus imitator OX=2715852 GN=VIPR2 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A2K5IRA2|A0A2K5IRA2_COLAP,96.181,419,16,0,18,436,1,419,0.0,828,A0A2K5IRA2,Vasoactive intestinal peptide receptor 2 OS=Colobus angolensis palliatus OX=336983 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A096N2B3|A0A096N2B3_PAPAN,95.413,436,18,1,5,438,4,439,0.0,825,A0A096N2B3,Vasoactive intestinal peptide receptor 2 OS=Papio anubis OX=9555 GN=VIPR2 PE=3 SV=2
sp|P41587|VIPR2_HUMAN,tr|A0A2K6S305|A0A2K6S305_SAIBB,95.592,431,19,0,8,438,107,537,0.0,820,A0A2K6S305,Vasoactive intestinal peptide receptor 2 OS=Saimiri boliviensis boliviensis OX=39432 GN=VIPR2 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A2K6S305|A0A2K6S305_SAIBB,85.000,20,3,0,1,20,1,20,4.0,39.7,A0A2K6S305,Vasoactive intestinal peptide receptor 2 OS=Saimiri boliviensis boliviensis OX=39432 GN=VIPR2 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A2K6PAZ7|A0A2K6PAZ7_RHIRO,95.139,432,21,0,7,438,1,432,0.0,820,A0A2K6PAZ7,Vasoactive intestinal peptide receptor 2 OS=Rhinopithecus roxellana OX=61622 GN=VIPR2 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A2K5CUH0|A0A2K5CUH0_AOTNA,92.644,435,13,1,4,438,4,419,0.0,818,A0A2K5CUH0,Vasoactive intestinal peptide receptor 2 OS=Aotus nancymaae OX=37293 GN=VIPR2 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A3Q7UUI8|A0A3Q7UUI8_URSAR,88.101,437,50,1,4,438,6,442,0.0,795,A0A3Q7UUI8,vasoactive intestinal polypeptide receptor 2 isoform X1 OS=Ursus arctos horribilis OX=116960 GN=VIPR2 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A5F9CEU4|A0A5F9CEU4_RABIT,91.244,434,36,1,7,438,4,437,0.0,791,A0A5F9CEU4,Vasoactive intestinal peptide receptor 2 OS=Oryctolagus cuniculus OX=9986 GN=VIPR2 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|H9GZT8|H9GZT8_HORSE,87.982,441,50,2,1,438,1,441,0.0,789,H9GZT8,Vasoactive intestinal peptide receptor 2 OS=Equus caballus OX=9796 GN=VIPR2 PE=3 SV=2
sp|P41587|VIPR2_HUMAN,tr|A0A2K5CUG5|A0A2K5CUG5_AOTNA,92.399,421,13,1,18,438,121,522,0.0,784,A0A2K5CUG5,Vasoactive intestinal peptide receptor 2 OS=Aotus nancymaae OX=37293 GN=VIPR2 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|H0WY86|H0WY86_OTOGA,87.671,438,51,2,3,438,5,441,0.0,784,H0WY86,Uncharacterized protein OS=Otolemur garnettii OX=30611 GN=VIPR2 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A3Q7N4L3|A0A3Q7N4L3_CALUR,89.437,426,45,0,13,438,17,442,0.0,783,A0A3Q7N4L3,vasoactive intestinal polypeptide receptor 2 OS=Callorhinus ursinus OX=34884 GN=VIPR2 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A6I9M2R6|A0A6I9M2R6_PERMB,87.588,427,53,0,12,438,11,437,0.0,781,A0A6I9M2R6,vasoactive intestinal polypeptide receptor 2 OS=Peromyscus maniculatus bairdii OX=230844 GN=Vipr2 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,sp|P41588|VIPR2_MOUSE,87.354,427,54,0,12,438,11,437,0.0,781,P41588,Vasoactive intestinal polypeptide receptor 2 OS=Mus musculus OX=10090 GN=Vipr2 PE=1 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A6J1YP75|A0A6J1YP75_ACIJB,88.498,426,49,0,13,438,17,442,0.0,780,A0A6J1YP75,vasoactive intestinal polypeptide receptor 2 isoform X1 OS=Acinonyx jubatus OX=32536 GN=VIPR2 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,sp|P35000|VIPR2_RAT,87.354,427,54,0,12,438,11,437,0.0,780,P35000,Vasoactive intestinal polypeptide receptor 2 OS=Rattus norvegicus OX=10116 GN=Vipr2 PE=2 SV=1
sp|P41587|VIPR2_HUMAN,tr|M3WAP4|M3WAP4_FELCA,88.263,426,50,0,13,438,17,442,0.0,780,M3WAP4,Vasoactive intestinal peptide receptor 2 OS=Felis catus OX=9685 GN=VIPR2 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|F6XPK0|F6XPK0_CALJA,97.680,388,9,0,51,438,23,410,0.0,779,F6XPK0,Uncharacterized protein OS=Callithrix jacchus OX=9483 GN=VIPR2 PE=3 SV=3
sp|P41587|VIPR2_HUMAN,tr|A0A287AYV5|A0A287AYV5_PIG,88.263,426,50,0,13,438,17,442,0.0,778,A0A287AYV5,Vasoactive intestinal peptide receptor 2 OS=Sus scrofa OX=9823 GN=VIPR2 PE=1 SV=1
sp|P41587|VIPR2_HUMAN,tr|G1SJS9|G1SJS9_RABIT,91.686,421,35,0,18,438,19,439,0.0,778,G1SJS9,Vasoactive intestinal peptide receptor 2 OS=Oryctolagus cuniculus OX=9986 GN=VIPR2 PE=3 SV=3
sp|P41587|VIPR2_HUMAN,tr|A0A6P3V9Y1|A0A6P3V9Y1_OCTDE,85.355,437,59,1,7,438,4,440,0.0,777,A0A6P3V9Y1,vasoactive intestinal polypeptide receptor 2 OS=Octodon degus OX=10160 GN=Vipr2 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A2U3WYD4|A0A2U3WYD4_ODORO,88.732,426,48,0,13,438,17,442,0.0,775,A0A2U3WYD4,vasoactive intestinal polypeptide receptor 2 isoform X1 OS=Odobenus rosmarus divergens OX=9708 GN=VIPR2 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A2K6GIK3|A0A2K6GIK3_PROCO,87.927,439,50,2,2,438,4,441,0.0,775,A0A2K6GIK3,Vasoactive intestinal peptide receptor 2 OS=Propithecus coquereli OX=379532 GN=VIPR2 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A384BXB6|A0A384BXB6_URSMA,88.361,421,49,0,18,438,3,423,0.0,772,A0A384BXB6,Vasoactive intestinal peptide receptor 2 OS=Ursus maritimus OX=29073 GN=VIPR2 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A2K6CQ94|A0A2K6CQ94_MACNE,92.308,416,26,3,18,429,155,568,0.0,771,A0A2K6CQ94,Vasoactive intestinal peptide receptor 2 OS=Macaca nemestrina OX=9545 GN=VIPR2 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A2K6CQ94|A0A2K6CQ94_MACNE,90.000,20,2,0,1,20,1,20,1.0,41.2,A0A2K6CQ94,Vasoactive intestinal peptide receptor 2 OS=Macaca nemestrina OX=9545 GN=VIPR2 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A2Y9TG63|A0A2Y9TG63_PHYMC,87.793,426,52,0,13,438,17,442,0.0,771,A0A2Y9TG63,vasoactive intestinal polypeptide receptor 2 isoform X1 OS=Physeter macrocephalus OX=9755 GN=VIPR2 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A6P6IAI8|A0A6P6IAI8_PUMCO,87.886,421,51,0,18,438,235,655,0.0,769,A0A6P6IAI8,vasoactive intestinal polypeptide receptor 2 OS=Puma concolor OX=9696 GN=VIPR2 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A452G0E4|A0A452G0E4_CAPHI,87.559,426,53,0,13,438,17,442,0.0,769,A0A452G0E4,Vasoactive intestinal peptide receptor 2 OS=Capra hircus OX=9925 GN=VIPR2 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A1U7QZQ9|A0A1U7QZQ9_MESAU,86.183,427,59,0,12,438,11,437,0.0,769,A0A1U7QZQ9,vasoactive intestinal polypeptide receptor 2 OS=Mesocricetus auratus OX=10036 GN=Vipr2 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A485MPM6|A0A485MPM6_LYNPA,87.264,424,54,0,15,438,15,438,0.0,768,A0A485MPM6,Vasoactive intestinal polypeptide OS=Lynx pardinus OX=191816 GN=LYPA_23C001486 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A6G1BGK2|A0A6G1BGK2_CROCR,87.264,424,54,0,15,438,1,424,0.0,768,A0A6G1BGK2,VIPR2 protein (Fragment) OS=Crocuta crocuta OX=9678 GN=Vipr2 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A4W2G6X8|A0A4W2G6X8_BOBOX,87.089,426,55,0,13,438,17,442,0.0,765,A0A4W2G6X8,Vasoactive intestinal peptide receptor 2 OS=Bos indicus x Bos taurus OX=30522 GN=VIPR2 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|F1MIT6|F1MIT6_BOVIN,87.089,426,55,0,13,438,17,442,0.0,765,F1MIT6,Vasoactive intestinal peptide receptor 2 OS=Bos taurus OX=9913 GN=VIPR2 PE=3 SV=3
sp|P41587|VIPR2_HUMAN,tr|A0A287ACB8|A0A287ACB8_PIG,83.742,449,50,1,13,438,17,465,0.0,765,A0A287ACB8,Vasoactive intestinal peptide receptor 2 OS=Sus scrofa OX=9823 GN=VIPR2 PE=1 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A6J3RXZ7|A0A6J3RXZ7_TURTR,86.468,436,56,2,6,438,4,439,0.0,765,A0A6J3RXZ7,vasoactive intestinal polypeptide receptor 2 isoform X1 OS=Tursiops truncatus OX=9739 GN=VIPR2 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|H0V744|H0V744_CAVPO,84.977,426,64,0,13,438,16,441,0.0,764,H0V744,Uncharacterized protein OS=Cavia porcellus OX=10141 GN=Vipr2 PE=3 SV=2
sp|P41587|VIPR2_HUMAN,tr|A0A5G2R380|A0A5G2R380_PIG,82.057,457,56,2,5,438,7,460,0.0,758,A0A5G2R380,Vasoactive intestinal peptide receptor 2 OS=Sus scrofa OX=9823 GN=VIPR2 PE=1 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A2Y9NRD0|A0A2Y9NRD0_DELLE,86.651,427,56,1,13,438,17,443,0.0,757,A0A2Y9NRD0,vasoactive intestinal polypeptide receptor 2 isoform X1 OS=Delphinapterus leucas OX=9749 GN=VIPR2 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A4W2D6T2|A0A4W2D6T2_BOBOX,86.936,421,55,0,18,438,5,425,0.0,755,A0A4W2D6T2,Vasoactive intestinal peptide receptor 2 OS=Bos indicus x Bos taurus OX=30522 GN=VIPR2 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A3Q7S483|A0A3Q7S483_VULVU,85.681,426,61,0,13,438,17,442,0.0,755,A0A3Q7S483,vasoactive intestinal polypeptide receptor 2 OS=Vulpes vulpes OX=9627 GN=VIPR2 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|H0W0G2|H0W0G2_CAVPO,85.036,421,63,0,18,438,1,421,0.0,755,H0W0G2,Uncharacterized protein OS=Cavia porcellus OX=10141 GN=Vipr2 PE=3 SV=2
sp|P41587|VIPR2_HUMAN,tr|F1P7Q6|F1P7Q6_CANLF,85.681,426,61,0,13,438,17,442,0.0,755,F1P7Q6,Vasoactive intestinal peptide receptor 2 OS=Canis lupus familiaris OX=9615 GN=VIPR2 PE=3 SV=2
sp|P41587|VIPR2_HUMAN,tr|A0A5F9D117|A0A5F9D117_RABIT,88.018,434,36,2,7,438,4,423,0.0,754,A0A5F9D117,Vasoactive intestinal peptide receptor 2 OS=Oryctolagus cuniculus OX=9986 GN=VIPR2 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|M3YEW9|M3YEW9_MUSPF,85.915,426,60,0,13,438,17,442,0.0,754,M3YEW9,Vasoactive intestinal peptide receptor 2 OS=Mustela putorius furo OX=9669 GN=VIPR2 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A2Y9E2F1|A0A2Y9E2F1_TRIMA,85.616,438,61,1,3,438,5,442,0.0,753,A0A2Y9E2F1,vasoactive intestinal polypeptide receptor 2 OS=Trichechus manatus latirostris OX=127582 GN=LOC101349834 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|L8I055|L8I055_9CETA,86.698,421,56,0,18,438,1,421,0.0,750,L8I055,Vasoactive intestinal polypeptide receptor 2 (Fragment) OS=Bos mutus OX=72004 GN=M91_18379 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A4W2D6U1|A0A4W2D6U1_BOBOX,81.360,456,55,1,13,438,17,472,0.0,749,A0A4W2D6U1,Vasoactive intestinal peptide receptor 2 OS=Bos indicus x Bos taurus OX=30522 GN=VIPR2 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A341C4V7|A0A341C4V7_NEOAA,86.118,425,58,1,15,438,175,599,0.0,749,A0A341C4V7,vasoactive intestinal polypeptide receptor 2 OS=Neophocaena asiaeorientalis asiaeorientalis OX=1706337 GN=VIPR2 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|G3SS81|G3SS81_LOXAF,87.886,421,51,0,18,438,1,421,0.0,749,G3SS81,Vasoactive intestinal peptide receptor 2 OS=Loxodonta africana OX=9785 GN=VIPR2 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A2Y9KK92|A0A2Y9KK92_ENHLU,84.977,426,64,0,13,438,17,442,0.0,747,A0A2Y9KK92,vasoactive intestinal polypeptide receptor 2 OS=Enhydra lutris kenyoni OX=391180 GN=LOC111154427 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A2Y9H9P9|A0A2Y9H9P9_NEOSC,80.388,464,55,1,11,438,78,541,0.0,745,A0A2Y9H9P9,vasoactive intestinal polypeptide receptor 2 OS=Neomonachus schauinslandi OX=29088 GN=VIPR2 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A6P3GLR6|A0A6P3GLR6_BISBI,85.511,421,61,0,18,438,86,506,0.0,741,A0A6P3GLR6,vasoactive intestinal polypeptide receptor 2 OS=Bison bison bison OX=43346 GN=VIPR2 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A671F9N5|A0A671F9N5_RHIFE,84.272,426,62,1,13,438,17,437,0.0,741,A0A671F9N5,Vasoactive intestinal peptide receptor 2 OS=Rhinolophus ferrumequinum OX=59479 GN=VIPR2 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A340XXL8|A0A340XXL8_LIPVE,84.687,431,61,2,13,438,17,447,0.0,741,A0A340XXL8,vasoactive intestinal polypeptide receptor 2 OS=Lipotes vexillifer OX=118797 GN=VIPR2 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A3Q0DCP8|A0A3Q0DCP8_CARSF,93.671,395,25,0,44,438,70,464,0.0,739,A0A3Q0DCP8,vasoactive intestinal polypeptide receptor 2 OS=Carlito syrichta OX=1868482 GN=VIPR2 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|F7CG94|F7CG94_MONDO,81.007,437,80,2,4,438,6,441,0.0,733,F7CG94,Uncharacterized protein OS=Monodelphis domestica OX=13616 GN=VIPR2 PE=3 SV=2
sp|P41587|VIPR2_HUMAN,tr|W5PKZ4|W5PKZ4_SHEEP,85.377,424,59,2,18,438,1,424,0.0,732,W5PKZ4,Uncharacterized protein OS=Ovis aries OX=9940 GN=VIPR2 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A452SLW6|A0A452SLW6_URSAM,81.963,438,69,4,3,438,5,434,0.0,729,A0A452SLW6,Vasoactive intestinal peptide receptor 2 OS=Ursus americanus OX=9643 GN=VIPR2 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A6J2MQE6|A0A6J2MQE6_9CHIR,81.690,426,78,0,13,438,17,442,0.0,727,A0A6J2MQE6,vasoactive intestinal polypeptide receptor 2 OS=Phyllostomus discolor OX=89673 GN=VIPR2 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A3Q2GXX1|A0A3Q2GXX1_HORSE,87.105,411,47,4,1,408,1,408,0.0,721,A0A3Q2GXX1,Vasoactive intestinal peptide receptor 2 OS=Equus caballus OX=9796 GN=VIPR2 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A3Q7TGF7|A0A3Q7TGF7_URSAR,88.175,389,46,0,50,438,37,425,0.0,710,A0A3Q7TGF7,vasoactive intestinal polypeptide receptor 2 isoform X2 OS=Ursus arctos horribilis OX=116960 GN=VIPR2 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A7N4NYK5|A0A7N4NYK5_SARHA,77.397,438,96,2,3,438,5,441,0.0,707,A0A7N4NYK5,Vasoactive intestinal peptide receptor 2 OS=Sarcophilus harrisii OX=9305 GN=VIPR2 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A6P5KLY5|A0A6P5KLY5_PHACI,80.365,438,83,2,3,438,5,441,0.0,706,A0A6P5KLY5,vasoactive intestinal polypeptide receptor 2 OS=Phascolarctos cinereus OX=38626 GN=VIPR2 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A5F5XJ08|A0A5F5XJ08_FELCA,90.566,371,35,0,13,383,17,387,0.0,705,A0A5F5XJ08,Vasoactive intestinal peptide receptor 2 OS=Felis catus OX=9685 GN=VIPR2 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A5F5XJ08|A0A5F5XJ08_FELCA,70.690,58,17,0,381,438,615,672,9.84e-14,82.4,A0A5F5XJ08,Vasoactive intestinal peptide receptor 2 OS=Felis catus OX=9685 GN=VIPR2 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A671FFA5|A0A671FFA5_RHIFE,80.986,426,62,2,13,438,17,423,0.0,704,A0A671FFA5,Vasoactive intestinal peptide receptor 2 OS=Rhinolophus ferrumequinum OX=59479 GN=VIPR2 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A6J3RY58|A0A6J3RY58_TURTR,88.831,385,41,1,6,388,4,388,0.0,704,A0A6J3RY58,vasoactive intestinal polypeptide receptor 2 isoform X2 OS=Tursiops truncatus OX=9739 GN=VIPR2 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A4D9EQ57|A0A4D9EQ57_9SAUR,76.993,439,100,1,1,438,1,439,0.0,702,A0A4D9EQ57,Vasoactive intestinal polypeptide receptor 2 OS=Platysternon megacephalum OX=55544 GN=DR999_PMT06552 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A1S3AMM0|A0A1S3AMM0_ERIEU,80.137,438,82,4,4,438,5,440,0.0,701,A0A1S3AMM0,vasoactive intestinal polypeptide receptor 2 isoform X1 OS=Erinaceus europaeus OX=9365 GN=VIPR2 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A6I8NKY0|A0A6I8NKY0_ORNAN,80.886,429,80,2,12,438,16,444,0.0,699,A0A6I8NKY0,Uncharacterized protein OS=Ornithorhynchus anatinus OX=9258 GN=VIPR2 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A287AYL6|A0A287AYL6_PIG,85.606,396,34,1,13,385,17,412,0.0,694,A0A287AYL6,Vasoactive intestinal peptide receptor 2 OS=Sus scrofa OX=9823 GN=VIPR2 PE=1 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A091ENU1|A0A091ENU1_FUKDA,83.969,393,63,0,46,438,46,438,0.0,692,A0A091ENU1,Vasoactive intestinal polypeptide receptor 2 OS=Fukomys damarensis OX=885580 GN=H920_01293 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A6J1YP73|A0A6J1YP73_ACIJB,80.986,426,45,1,13,438,17,406,0.0,692,A0A6J1YP73,vasoactive intestinal polypeptide receptor 2 isoform X2 OS=Acinonyx jubatus OX=32536 GN=VIPR2 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A5F4CRG9|A0A5F4CRG9_CANLF,84.500,400,60,1,41,438,23,422,0.0,687,A0A5F4CRG9,Vasoactive intestinal peptide receptor 2 OS=Canis lupus familiaris OX=9615 GN=VIPR2 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|G1PY89|G1PY89_MYOLU,76.620,432,98,1,10,438,14,445,0.0,687,G1PY89,Uncharacterized protein OS=Myotis lucifugus OX=59463 GN=VIPR2 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A674HWC9|A0A674HWC9_TERCA,75.854,439,105,1,1,438,1,439,0.0,684,A0A674HWC9,Vasoactive intestinal peptide receptor 2 OS=Terrapene carolina triunguis OX=2587831 GN=VIPR2 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A2Y9TE36|A0A2Y9TE36_PHYMC,80.282,426,48,1,13,438,17,406,0.0,684,A0A2Y9TE36,vasoactive intestinal polypeptide receptor 2 isoform X2 OS=Physeter macrocephalus OX=9755 GN=VIPR2 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A6I8NVS8|A0A6I8NVS8_ORNAN,75.764,458,80,3,12,438,16,473,0.0,684,A0A6I8NVS8,Uncharacterized protein OS=Ornithorhynchus anatinus OX=9258 GN=VIPR2 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A6J3RYW6|A0A6J3RYW6_TURTR,79.128,436,52,3,6,438,4,403,0.0,679,A0A6J3RYW6,vasoactive intestinal polypeptide receptor 2 isoform X3 OS=Tursiops truncatus OX=9739 GN=VIPR2 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|G5BHJ1|G5BHJ1_HETGA,75.000,448,57,2,46,438,2,449,0.0,676,G5BHJ1,Vasoactive intestinal polypeptide receptor 2 OS=Heterocephalus glaber OX=10181 GN=GW7_06245 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A1U7S3P2|A0A1U7S3P2_ALLSI,73.333,435,114,1,4,438,2,434,0.0,675,A0A1U7S3P2,vasoactive intestinal polypeptide receptor 2 OS=Alligator sinensis OX=38654 GN=VIPR2 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A5F4C6C7|A0A5F4C6C7_CANLF,88.493,365,42,0,18,382,16,380,0.0,675,A0A5F4C6C7,Vasoactive intestinal peptide receptor 2 OS=Canis lupus familiaris OX=9615 GN=VIPR2 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A2Y9NKM7|A0A2Y9NKM7_DELLE,79.157,427,52,2,13,438,17,407,0.0,670,A0A2Y9NKM7,vasoactive intestinal polypeptide receptor 2 isoform X2 OS=Delphinapterus leucas OX=9749 GN=VIPR2 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|M7BV94|M7BV94_CHEMY,76.303,422,99,1,18,438,2,423,0.0,669,M7BV94,Vasoactive intestinal polypeptide receptor 2 (Fragment) OS=Chelonia mydas OX=8469 GN=UY3_01629 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A4X2KSW1|A0A4X2KSW1_VOMUR,78.311,438,89,3,3,438,5,438,0.0,668,A0A4X2KSW1,Vasoactive intestinal peptide receptor 2 OS=Vombatus ursinus OX=29139 GN=VIPR2 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|K7FMV5|K7FMV5_PELSI,74.824,425,106,1,15,438,16,440,0.0,666,K7FMV5,Vasoactive intestinal peptide receptor 2 OS=Pelodiscus sinensis OX=13735 GN=VIPR2 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A6I9KFS3|A0A6I9KFS3_CHRAS,84.576,389,60,0,50,438,10,398,0.0,657,A0A6I9KFS3,vasoactive intestinal polypeptide receptor 2-like OS=Chrysochloris asiatica OX=185453 GN=VIPR2 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A091FXC4|A0A091FXC4_9AVES,73.882,425,110,1,15,438,2,426,0.0,654,A0A091FXC4,Vasoactive intestinal polypeptide receptor 2 (Fragment) OS=Cuculus canorus OX=55661 GN=N303_03811 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A2R8ZZ81|A0A2R8ZZ81_PANPA,98.758,322,4,0,117,438,100,421,0.0,648,A0A2R8ZZ81,Vasoactive intestinal peptide receptor 2 OS=Pan paniscus OX=9597 GN=VIPR2 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A091EHH2|A0A091EHH2_CORBR,73.176,425,113,1,15,438,2,426,0.0,647,A0A091EHH2,Vasoactive intestinal polypeptide receptor 2 (Fragment) OS=Corvus brachyrhynchos OX=85066 GN=N302_12133 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|L5L6Z2|L5L6Z2_PTEAL,81.443,388,67,2,51,438,6,388,0.0,647,L5L6Z2,Vasoactive intestinal polypeptide receptor 2 OS=Pteropus alecto OX=9402 GN=PAL_GLEAN10003602 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A663DUE9|A0A663DUE9_AQUCH,73.576,439,115,1,1,438,1,439,0.0,645,A0A663DUE9,Vasoactive intestinal peptide receptor 2 OS=Aquila chrysaetos chrysaetos OX=223781 GN=VIPR2 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A2I2Y973|A0A2I2Y973_GORGO,93.084,347,20,1,92,438,80,422,0.0,645,A0A2I2Y973,G_PROTEIN_RECEP_F2_4 domain-containing protein OS=Gorilla gorilla gorilla OX=9595 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A2I3RKP7|A0A2I3RKP7_PANTR,98.447,322,5,0,117,438,100,421,0.0,644,A0A2I3RKP7,Vasoactive intestinal peptide receptor 2 OS=Pan troglodytes OX=9598 GN=VIPR2 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A2I0U9L7|A0A2I0U9L7_LIMLA,73.121,439,117,1,1,438,1,439,0.0,642,A0A2I0U9L7,Vasoactive intestinal polypeptide receptor 2 OS=Limosa lapponica baueri OX=1758121 GN=llap_6949 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A6J2GN64|A0A6J2GN64_9PASS,73.349,439,116,1,1,438,1,439,0.0,642,A0A6J2GN64,vasoactive intestinal polypeptide receptor 2 OS=Pipra filicauda OX=649802 GN=VIPR2 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A091UFQ3|A0A091UFQ3_PHORB,74.588,425,107,1,15,438,2,426,0.0,641,A0A091UFQ3,Vasoactive intestinal polypeptide receptor 2 (Fragment) OS=Phoenicopterus ruber ruber OX=9218 GN=N337_07512 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A099ZJB5|A0A099ZJB5_TINGU,74.588,425,107,1,15,438,2,426,0.0,641,A0A099ZJB5,Vasoactive intestinal polypeptide receptor 2 (Fragment) OS=Tinamus guttatus OX=94827 GN=N309_07538 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A663DUE1|A0A663DUE1_AQUCH,74.824,425,106,1,15,438,11,435,0.0,640,A0A663DUE1,Vasoactive intestinal peptide receptor 2 OS=Aquila chrysaetos chrysaetos OX=223781 GN=VIPR2 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A2I3G4A2|A0A2I3G4A2_NOMLE,98.438,320,5,0,119,438,102,421,0.0,640,A0A2I3G4A2,G_PROTEIN_RECEP_F2_4 domain-containing protein OS=Nomascus leucogenys OX=61853 GN=VIPR2 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A6J3CMV3|A0A6J3CMV3_AYTFU,73.563,435,114,1,5,438,4,438,0.0,639,A0A6J3CMV3,vasoactive intestinal polypeptide receptor 2 OS=Aythya fuligula OX=219594 GN=VIPR2 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A1V4KLL5|A0A1V4KLL5_PATFA,72.665,439,119,1,1,438,1,439,0.0,639,A0A1V4KLL5,Vasoactive intestinal polypeptide receptor 2 OS=Patagioenas fasciata monilis OX=372326 GN=VIPR2 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A091MV47|A0A091MV47_APAVI,74.588,425,107,1,15,438,2,426,0.0,639,A0A091MV47,Vasoactive intestinal polypeptide receptor 2 (Fragment) OS=Apaloderma vittatum OX=57397 GN=N311_03345 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A402FAH7|A0A402FAH7_9SAUR,72.275,422,115,2,18,438,1,421,0.0,637,A0A402FAH7,Uncharacterized protein (Fragment) OS=Paroedura picta OX=143630 GN=parPi_0015261 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A091QBP0|A0A091QBP0_MERNU,74.588,425,107,1,15,438,2,426,0.0,637,A0A091QBP0,Vasoactive intestinal polypeptide receptor 2 (Fragment) OS=Merops nubicus OX=57421 GN=N331_07127 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A218UTB0|A0A218UTB0_9PASE,73.121,439,115,2,1,438,1,437,0.0,637,A0A218UTB0,Vasoactive intestinal polypeptide receptor 2 OS=Lonchura striata domestica OX=299123 GN=VIPR2 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A091KQU8|A0A091KQU8_COLST,74.118,425,109,1,15,438,2,426,0.0,637,A0A091KQU8,Vasoactive intestinal polypeptide receptor 2 (Fragment) OS=Colius striatus OX=57412 GN=N325_12731 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A2K6PB68|A0A2K6PB68_RHIRO,91.117,349,29,1,90,438,75,421,0.0,637,A0A2K6PB68,Vasoactive intestinal peptide receptor 2 OS=Rhinopithecus roxellana OX=61622 GN=VIPR2 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A2K6MRR8|A0A2K6MRR8_RHIBE,91.117,349,29,1,90,438,75,421,0.0,637,A0A2K6MRR8,G_PROTEIN_RECEP_F2_4 domain-containing protein OS=Rhinopithecus bieti OX=61621 GN=VIPR2 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A093K690|A0A093K690_STRCA,74.353,425,108,1,15,438,2,426,0.0,637,A0A093K690,Vasoactive intestinal polypeptide receptor 2 (Fragment) OS=Struthio camelus australis OX=441894 GN=N308_06775 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A091KED8|A0A091KED8_9GRUI,74.353,425,108,1,15,438,2,426,0.0,637,A0A091KED8,Vasoactive intestinal polypeptide receptor 2 (Fragment) OS=Chlamydotis macqueenii OX=187382 GN=N324_00801 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A3L8T0U9|A0A3L8T0U9_CHLGU,70.460,457,116,1,1,438,1,457,0.0,636,A0A3L8T0U9,Uncharacterized protein OS=Chloebia gouldiae OX=44316 GN=DV515_00001358 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A0Q3USQ2|A0A0Q3USQ2_AMAAE,72.665,439,119,1,1,438,1,439,0.0,635,A0A0Q3USQ2,Vasoactive intestinal polypeptide receptor 2-like protein OS=Amazona aestiva OX=12930 GN=AAES_75591 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A093F9N4|A0A093F9N4_TYTAL,74.118,425,109,1,15,438,2,426,0.0,635,A0A093F9N4,Vasoactive intestinal polypeptide receptor 2 (Fragment) OS=Tyto alba OX=56313 GN=N341_01444 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A093GI94|A0A093GI94_DRYPU,73.647,425,111,1,15,438,2,426,0.0,634,A0A093GI94,Vasoactive intestinal polypeptide receptor 2 (Fragment) OS=Dryobates pubescens OX=118200 GN=N307_00542 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A0A0AJS0|A0A0A0AJS0_CHAVO,73.882,425,110,1,15,438,2,426,0.0,634,A0A0A0AJS0,Vasoactive intestinal polypeptide receptor 2 (Fragment) OS=Charadrius vociferus OX=50402 GN=N301_05998 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|G1LPG6|G1LPG6_AILME,88.068,352,42,0,87,438,54,405,0.0,632,G1LPG6,Vasoactive intestinal peptide receptor 2 OS=Ailuropoda melanoleuca OX=9646 GN=VIPR2 PE=3 SV=2
sp|P41587|VIPR2_HUMAN,tr|G1N143|G1N143_MELGA,74.118,425,108,2,15,438,6,429,0.0,632,G1N143,Vasoactive intestinal peptide receptor 2 OS=Meleagris gallopavo OX=9103 GN=VIPR2 PE=3 SV=2
sp|P41587|VIPR2_HUMAN,tr|A0A2K5Q2R6|A0A2K5Q2R6_CEBIM,88.920,352,39,0,87,438,70,421,0.0,632,A0A2K5Q2R6,Vasoactive intestinal peptide receptor 2 OS=Cebus imitator OX=2715852 GN=VIPR2 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|Q56IA1|Q56IA1_CHICK,74.408,422,106,2,18,438,19,439,0.0,630,Q56IA1,VPAC2 receptor OS=Gallus gallus OX=9031 GN=VPAC2 PE=2 SV=1
sp|P41587|VIPR2_HUMAN,tr|R0M4K5|R0M4K5_ANAPL,73.647,425,111,1,15,438,2,426,0.0,630,R0M4K5,Vasoactive intestinal polypeptide receptor 2 (Fragment) OS=Anas platyrhynchos OX=8839 GN=Anapl_10580 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A669P1C9|A0A669P1C9_PHACC,74.645,422,105,2,18,438,19,439,0.0,629,A0A669P1C9,Vasoactive intestinal peptide receptor 2 OS=Phasianus colchicus OX=9054 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A087R0U6|A0A087R0U6_APTFO,73.412,425,112,1,15,438,2,426,0.0,629,A0A087R0U6,Vasoactive intestinal polypeptide receptor 2 (Fragment) OS=Aptenodytes forsteri OX=9233 GN=AS27_06950 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A452IWE4|A0A452IWE4_9SAUR,78.646,384,81,1,1,383,1,384,0.0,627,A0A452IWE4,Vasoactive intestinal peptide receptor 2 OS=Gopherus agassizii OX=38772 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A6I9HPX9|A0A6I9HPX9_GEOFO,73.647,425,110,2,15,438,33,456,0.0,625,A0A6I9HPX9,vasoactive intestinal polypeptide receptor 2 OS=Geospiza fortis OX=48883 GN=VIPR2 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A093PGD3|A0A093PGD3_PYGAD,73.176,425,113,1,15,438,2,426,0.0,625,A0A093PGD3,Vasoactive intestinal polypeptide receptor 2 (Fragment) OS=Pygoscelis adeliae OX=9238 GN=AS28_05650 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A2K5IRL9|A0A2K5IRL9_COLAP,90.202,347,32,1,90,436,75,419,0.0,625,A0A2K5IRL9,Vasoactive intestinal peptide receptor 2 OS=Colobus angolensis palliatus OX=336983 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A091PMP0|A0A091PMP0_HALAL,72.941,425,114,1,15,438,2,426,0.0,625,A0A091PMP0,Vasoactive intestinal polypeptide receptor 2 (Fragment) OS=Haliaeetus albicilla OX=8969 GN=N329_02542 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A6J3RY17|A0A6J3RY17_TURTR,86.761,355,46,1,85,438,36,390,0.0,624,A0A6J3RY17,vasoactive intestinal polypeptide receptor 2 isoform X4 OS=Tursiops truncatus OX=9739 GN=VIPR2 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A6J3F577|A0A6J3F577_SAPAP,96.250,320,12,0,119,438,51,370,0.0,624,A0A6J3F577,vasoactive intestinal polypeptide receptor 2 isoform X3 OS=Sapajus apella OX=9515 GN=VIPR2 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A663M3Y6|A0A663M3Y6_ATHCN,74.279,416,106,1,24,438,12,427,0.0,622,A0A663M3Y6,Vasoactive intestinal peptide receptor 2 OS=Athene cunicularia OX=194338 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A2K5P3I5|A0A2K5P3I5_CERAT,90.704,355,31,1,86,438,67,421,0.0,620,A0A2K5P3I5,Vasoactive intestinal peptide receptor 2 OS=Cercocebus atys OX=9531 GN=VIPR2 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A2K5Y283|A0A2K5Y283_MANLE,92.442,344,26,0,95,438,78,421,0.0,618,A0A2K5Y283,Vasoactive intestinal peptide receptor 2 OS=Mandrillus leucophaeus OX=9568 GN=VIPR2 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A670J5C9|A0A670J5C9_PODMU,75.250,400,96,3,40,438,2,399,0.0,618,A0A670J5C9,Uncharacterized protein OS=Podarcis muralis OX=64176 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A672UJ95|A0A672UJ95_STRHB,72.300,426,116,2,15,438,11,436,0.0,618,A0A672UJ95,Vasoactive intestinal peptide receptor 2 OS=Strigops habroptila OX=2489341 GN=VIPR2 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A2K6S2Z7|A0A2K6S2Z7_SAIBB,92.647,340,25,0,99,438,82,421,0.0,616,A0A2K6S2Z7,Vasoactive intestinal peptide receptor 2 OS=Saimiri boliviensis boliviensis OX=39432 GN=VIPR2 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A5F5Y394|A0A5F5Y394_FELCA,81.941,371,31,1,13,383,17,351,0.0,616,A0A5F5Y394,Vasoactive intestinal peptide receptor 2 OS=Felis catus OX=9685 GN=VIPR2 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A5F5Y394|A0A5F5Y394_FELCA,70.690,58,17,0,381,438,579,636,9.60e-14,82.4,A0A5F5Y394,Vasoactive intestinal peptide receptor 2 OS=Felis catus OX=9685 GN=VIPR2 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A2I3LHI8|A0A2I3LHI8_PAPAN,92.151,344,27,0,95,438,78,421,0.0,615,A0A2I3LHI8,Vasoactive intestinal peptide receptor 2 OS=Papio anubis OX=9555 GN=VIPR2 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A5F4CUH9|A0A5F4CUH9_CANLF,88.889,333,37,0,51,383,64,396,0.0,615,A0A5F4CUH9,Vasoactive intestinal peptide receptor 2 OS=Canis lupus familiaris OX=9615 GN=VIPR2 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A6J0SKJ3|A0A6J0SKJ3_9SAUR,68.864,440,130,4,4,438,2,439,0.0,613,A0A6J0SKJ3,vasoactive intestinal polypeptide receptor 2 OS=Pogona vitticeps OX=103695 GN=VIPR2 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A093QZD7|A0A093QZD7_PHACA,72.028,429,112,2,18,438,1,429,0.0,612,A0A093QZD7,Vasoactive intestinal polypeptide receptor 2 (Fragment) OS=Phalacrocorax carbo OX=9209 GN=N336_02724 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A091IU07|A0A091IU07_EGRGA,72.941,425,114,1,15,438,2,426,0.0,611,A0A091IU07,Vasoactive intestinal polypeptide receptor 2 (Fragment) OS=Egretta garzetta OX=188379 GN=Z169_03604 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A670J960|A0A670J960_PODMU,76.289,388,90,2,51,438,22,407,0.0,611,A0A670J960,Uncharacterized protein OS=Podarcis muralis OX=64176 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A670J7V1|A0A670J7V1_PODMU,76.289,388,90,2,51,438,31,416,0.0,610,A0A670J7V1,Uncharacterized protein OS=Podarcis muralis OX=64176 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A091VNA7|A0A091VNA7_OPIHO,71.294,425,117,2,15,438,2,422,0.0,605,A0A091VNA7,Vasoactive intestinal polypeptide receptor 2 (Fragment) OS=Opisthocomus hoazin OX=30419 GN=N306_00727 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A151PCV8|A0A151PCV8_ALLMI,69.740,423,123,1,16,438,18,435,0.0,603,A0A151PCV8,Vasoactive intestinal polypeptide receptor 2 isoform A OS=Alligator mississippiensis OX=8496 GN=VIPR2-1 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A151PCZ0|A0A151PCZ0_ALLMI,68.287,432,120,2,16,438,18,441,0.0,601,A0A151PCZ0,Vasoactive intestinal polypeptide receptor 2 isoform B OS=Alligator mississippiensis OX=8496 GN=VIPR2-1 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|G1KAG6|G1KAG6_ANOCA,67.447,427,134,3,13,438,15,437,0.0,600,G1KAG6,Uncharacterized protein OS=Anolis carolinensis OX=28377 GN=VIPR2 PE=3 SV=2
sp|P41587|VIPR2_HUMAN,tr|A0A091UNG8|A0A091UNG8_NIPNI,70.862,429,120,2,15,438,2,430,0.0,600,A0A091UNG8,Vasoactive intestinal polypeptide receptor 2 (Fragment) OS=Nipponia nippon OX=128390 GN=Y956_00150 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A6J3RY71|A0A6J3RY71_TURTR,89.441,322,32,1,6,325,4,325,0.0,598,A0A6J3RY71,vasoactive intestinal polypeptide receptor 2 isoform X5 OS=Tursiops truncatus OX=9739 GN=VIPR2 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A2I0MQV6|A0A2I0MQV6_COLLI,74.750,400,100,1,40,438,2,401,0.0,597,A0A2I0MQV6,Vasoactive intestinal peptide receptor 2 OS=Columba livia OX=8932 GN=VIPR2 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A2Y9TC81|A0A2Y9TC81_PHYMC,91.054,313,28,0,13,325,17,329,0.0,596,A0A2Y9TC81,vasoactive intestinal polypeptide receptor 2 isoform X3 OS=Physeter macrocephalus OX=9755 GN=VIPR2 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A091PYM1|A0A091PYM1_LEPDC,76.031,388,93,0,51,438,10,397,0.0,595,A0A091PYM1,Vasoactive intestinal polypeptide receptor 2 (Fragment) OS=Leptosomus discolor OX=188344 GN=N330_14047 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|U3JWU4|U3JWU4_FICAL,74.750,400,99,2,40,438,2,400,0.0,594,U3JWU4,Vasoactive intestinal peptide receptor 2 OS=Ficedula albicollis OX=59894 GN=VIPR2 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A452CFJ1|A0A452CFJ1_BALAS,87.688,333,41,0,106,438,1,333,0.0,593,A0A452CFJ1,vasoactive intestinal polypeptide receptor 2 OS=Balaenoptera acutorostrata scammoni OX=310752 GN=VIPR2 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A6I9XN40|A0A6I9XN40_9SAUR,70.000,430,122,5,11,438,11,435,0.0,592,A0A6I9XN40,vasoactive intestinal polypeptide receptor 2-like OS=Thamnophis sirtalis OX=35019 GN=LOC106541303 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A2Y9NRH3|A0A2Y9NRH3_DELLE,89.744,312,32,0,13,324,17,328,0.0,585,A0A2Y9NRH3,vasoactive intestinal polypeptide receptor 2 isoform X3 OS=Delphinapterus leucas OX=9749 GN=VIPR2 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A5F4DDJ0|A0A5F4DDJ0_CANLF,79.452,365,39,1,18,382,16,344,0.0,584,A0A5F4DDJ0,Vasoactive intestinal peptide receptor 2 OS=Canis lupus familiaris OX=9615 GN=VIPR2 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A6P9ALP7|A0A6P9ALP7_PANGU,69.302,430,125,5,11,438,11,435,0.0,581,A0A6P9ALP7,vasoactive intestinal polypeptide receptor 2 isoform X2 OS=Pantherophis guttatus OX=94885 GN=VIPR2 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A6J3RY02|A0A6J3RY02_TURTR,86.527,334,44,1,106,438,1,334,0.0,580,A0A6J3RY02,vasoactive intestinal polypeptide receptor 2 isoform X6 OS=Tursiops truncatus OX=9739 GN=VIPR2 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A6P9AJ54|A0A6P9AJ54_PANGU,68.360,433,131,4,7,438,17,444,0.0,574,A0A6P9AJ54,vasoactive intestinal polypeptide receptor 2 isoform X1 OS=Pantherophis guttatus OX=94885 GN=VIPR2 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A2K6CQ91|A0A2K6CQ91_MACNE,80.926,367,62,4,69,429,43,407,0.0,570,A0A2K6CQ91,Vasoactive intestinal peptide receptor 2 OS=Macaca nemestrina OX=9545 GN=VIPR2 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A2K5CUH2|A0A2K5CUH2_AOTNA,84.375,352,36,1,87,438,64,396,0.0,564,A0A2K5CUH2,Vasoactive intestinal peptide receptor 2 OS=Aotus nancymaae OX=37293 GN=VIPR2 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|H0YR68|H0YR68_TAEGU,71.182,406,107,3,1,398,1,404,0.0,564,H0YR68,Uncharacterized protein OS=Taeniopygia guttata OX=59729 GN=VIPR2 PE=3 SV=2
sp|P41587|VIPR2_HUMAN,tr|A0A3Q2UGZ2|A0A3Q2UGZ2_CHICK,75.616,365,88,1,18,381,19,383,0.0,558,A0A3Q2UGZ2,Uncharacterized protein OS=Gallus gallus OX=9031 GN=VIPR2 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A6P8PYF2|A0A6P8PYF2_GEOSA,63.466,427,151,4,11,436,20,442,0.0,558,A0A6P8PYF2,vasoactive intestinal polypeptide receptor 2 isoform X1 OS=Geotrypetes seraphini OX=260995 GN=VIPR2 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A6P9AMI6|A0A6P9AMI6_PANGU,69.512,410,119,4,30,438,4,408,0.0,556,A0A6P9AMI6,vasoactive intestinal polypeptide receptor 2 isoform X3 OS=Pantherophis guttatus OX=94885 GN=VIPR2 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A6J1VJD7|A0A6J1VJD7_9SAUR,65.986,441,142,6,1,438,1,436,0.0,555,A0A6J1VJD7,vasoactive intestinal polypeptide receptor 2 OS=Notechis scutatus OX=8663 GN=VIPR2 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A6P7XQ22|A0A6P7XQ22_9AMPH,61.839,435,162,3,2,435,3,434,0.0,551,A0A6P7XQ22,vasoactive intestinal polypeptide receptor 2 OS=Microcaecilia unicolor OX=1415580 GN=VIPR2 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A6P8PF81|A0A6P8PF81_GEOSA,63.702,416,147,3,22,436,6,418,0.0,550,A0A6P8PF81,vasoactive intestinal polypeptide receptor 2 isoform X2 OS=Geotrypetes seraphini OX=260995 GN=VIPR2 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A4W2EU19|A0A4W2EU19_BOBOX,85.358,321,47,0,118,438,99,419,0.0,550,A0A4W2EU19,G_PROTEIN_RECEP_F2_4 domain-containing protein OS=Bos indicus x Bos taurus OX=30522 GN=VIPR2 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A670ZSZ2|A0A670ZSZ2_PSETE,66.197,426,138,4,14,438,5,425,0.0,546,A0A670ZSZ2,Vasoactive intestinal peptide receptor 2 OS=Pseudonaja textilis OX=8673 GN=VIPR2 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A4W6BZQ3|A0A4W6BZQ3_LATCA,60.811,444,161,6,1,438,1,437,0.0,546,A0A4W6BZQ3,Vasoactive intestinal peptide receptor 2 OS=Lates calcarifer OX=8187 GN=VIPR2 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A6P3RBZ3|A0A6P3RBZ3_PTEVA,83.226,310,50,1,15,324,59,366,0.0,545,A0A6P3RBZ3,vasoactive intestinal polypeptide receptor 2 OS=Pteropus vampyrus OX=132908 GN=VIPR2 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A6P8PUD4|A0A6P8PUD4_GEOSA,64.303,409,142,3,29,436,3,408,0.0,544,A0A6P8PUD4,vasoactive intestinal polypeptide receptor 2 isoform X4 OS=Geotrypetes seraphini OX=260995 GN=VIPR2 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|W5N3J5|W5N3J5_LEPOC,62.812,441,157,5,1,438,2,438,0.0,543,W5N3J5,Vasoactive intestinal peptide receptor 2 OS=Lepisosteus oculatus OX=7918 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|S7MNW4|S7MNW4_MYOBR,69.095,398,118,2,46,438,10,407,0.0,543,S7MNW4,Vasoactive intestinal polypeptide receptor 2 OS=Myotis brandtii OX=109478 GN=D623_10002173 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|W5N3K4|W5N3K4_LEPOC,62.903,434,154,5,8,438,7,436,0.0,542,W5N3K4,Vasoactive intestinal peptide receptor 2 OS=Lepisosteus oculatus OX=7918 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A4U1EDU3|A0A4U1EDU3_MONMO,80.233,344,44,2,119,438,15,358,0.0,536,A0A4U1EDU3,G_PROTEIN_RECEP_F2_4 domain-containing protein OS=Monodon monoceros OX=40151 GN=EI555_018017 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A6P7K793|A0A6P7K793_9TELE,60.135,444,164,7,1,438,1,437,0.0,536,A0A6P7K793,vasoactive intestinal polypeptide receptor 2 OS=Parambassis ranga OX=210632 GN=vipr2 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A2U9BHY5|A0A2U9BHY5_SCOMX,59.688,449,163,7,1,438,1,442,0.0,532,A0A2U9BHY5,Putative vasoactive intestinal polypeptide receptor 2 OS=Scophthalmus maximus OX=52904 GN=SMAX5B_004638 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A437CF90|A0A437CF90_ORYJA,60.471,425,159,4,18,438,18,437,0.0,530,A0A437CF90,Uncharacterized protein OS=Oryzias javanicus OX=123683 GN=OJAV_G00168670 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A671Z2R8|A0A671Z2R8_SPAAU,61.358,427,153,6,18,438,18,438,0.0,529,A0A671Z2R8,Vasoactive intestinal polypeptide receptor 2-like OS=Sparus aurata OX=8175 GN=VIPR2 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A1S3LVW9|A0A1S3LVW9_SALSA,60.046,433,160,6,8,436,10,433,0.0,529,A0A1S3LVW9,vasoactive intestinal polypeptide receptor 2-like OS=Salmo salar OX=8030 GN=LOC106568823 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A6J2RL70|A0A6J2RL70_COTGO,59.551,445,164,8,1,438,1,436,0.0,529,A0A6J2RL70,vasoactive intestinal polypeptide receptor 2 OS=Cottoperca gobio OX=56716 GN=vipr2 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A4W5P9S2|A0A4W5P9S2_9TELE,59.770,435,162,6,8,438,10,435,0.0,527,A0A4W5P9S2,Vasoactive intestinal peptide receptor 2 OS=Hucho hucho OX=62062 GN=VIPR2 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A2I4CBY2|A0A2I4CBY2_9TELE,58.239,443,173,5,1,438,1,436,0.0,527,A0A2I4CBY2,vasoactive intestinal polypeptide receptor 2 isoform X1 OS=Austrofundulus limnaeus OX=52670 GN=vipr2 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A087XVS6|A0A087XVS6_POEFO,57.895,437,175,4,6,438,6,437,0.0,527,A0A087XVS6,Vasoactive intestinal peptide receptor 2 OS=Poecilia formosa OX=48698 GN=VIPR2 PE=3 SV=2
sp|P41587|VIPR2_HUMAN,tr|A0A1S3R1G8|A0A1S3R1G8_SALSA,58.597,442,173,5,1,438,1,436,0.0,527,A0A1S3R1G8,vasoactive intestinal polypeptide receptor 2-like OS=Salmo salar OX=8030 GN=LOC106599477 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A2I4CBX8|A0A2I4CBX8_9TELE,58.879,428,166,4,16,438,7,429,0.0,525,A0A2I4CBX8,vasoactive intestinal polypeptide receptor 2 isoform X2 OS=Austrofundulus limnaeus OX=52670 GN=vipr2 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A6P8GVY0|A0A6P8GVY0_CLUHA,59.770,435,167,5,8,438,18,448,0.0,524,A0A6P8GVY0,vasoactive intestinal polypeptide receptor 2-like isoform X1 OS=Clupea harengus OX=7950 GN=LOC105894700 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|I3KC94|I3KC94_ORENI,58.597,442,171,5,1,438,1,434,0.0,524,I3KC94,Uncharacterized protein OS=Oreochromis niloticus OX=8128 GN=VIPR2 PE=3 SV=2
sp|P41587|VIPR2_HUMAN,tr|A0A1L8FVA9|A0A1L8FVA9_XENLA,61.538,442,159,4,1,438,1,435,0.0,521,A0A1L8FVA9,Uncharacterized protein OS=Xenopus laevis OX=8355 GN=XELAEV_18030696mg PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A5C6P4K6|A0A5C6P4K6_9TELE,58.014,443,171,6,1,438,1,433,0.0,519,A0A5C6P4K6,Vasoactive intestinal polypeptide receptor 2 OS=Takifugu flavidus OX=433684 GN=D4764_15G0004510 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A5N3XS47|A0A5N3XS47_MUNRE,70.103,388,63,3,51,438,32,366,0.0,518,A0A5N3XS47,Uncharacterized protein OS=Muntiacus reevesi OX=9886 GN=FD755_012745 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A6P8GL63|A0A6P8GL63_CLUHA,61.045,421,156,5,22,438,29,445,1.08e-180,519,A0A6P8GL63,vasoactive intestinal polypeptide receptor 2-like isoform X2 OS=Clupea harengus OX=7950 GN=LOC105894700 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A1L8FQK7|A0A1L8FQK7_XENLA,61.765,442,160,4,1,438,19,455,1.13e-180,519,A0A1L8FQK7,Uncharacterized protein OS=Xenopus laevis OX=8355 GN=XELAEV_18032843mg PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A6J2V141|A0A6J2V141_CHACN,59.441,429,165,4,18,438,20,447,1.71e-180,518,A0A6J2V141,vasoactive intestinal polypeptide receptor 2-like OS=Chanos chanos OX=29144 GN=LOC115807906 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A3Q3GBS5|A0A3Q3GBS5_9LABR,57.528,445,175,6,1,438,1,438,1.91e-180,518,A0A3Q3GBS5,Vasoactive intestinal peptide receptor 2 OS=Labrus bergylta OX=56723 GN=VIPR2 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A3Q3BR07|A0A3Q3BR07_KRYMA,58.219,438,170,7,9,438,6,438,2.00e-180,518,A0A3Q3BR07,Vasoactive intestinal peptide receptor 2 OS=Kryptolebias marmoratus OX=37003 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A674MYW6|A0A674MYW6_TAKRU,57.788,443,172,6,1,438,1,433,2.45e-180,517,A0A674MYW6,Uncharacterized protein OS=Takifugu rubripes OX=31033 GN=VIPR2 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A401S9N4|A0A401S9N4_CHIPU,57.500,440,175,4,1,438,1,430,3.49e-180,517,A0A401S9N4,Uncharacterized protein OS=Chiloscyllium punctatum OX=137246 GN=chiPu_0005481 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A5E4CPD1|A0A5E4CPD1_MARMO,84.797,296,41,2,146,438,1,295,7.45e-179,508,A0A5E4CPD1,G_PROTEIN_RECEP_F2_4 domain-containing protein OS=Marmota monax OX=9995 GN=MONAX_5E014657 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A6P8UPV2|A0A6P8UPV2_GYMAC,59.729,442,168,6,1,438,1,436,9.30e-179,513,A0A6P8UPV2,vasoactive intestinal polypeptide receptor 2-like OS=Gymnodraco acuticeps OX=8218 GN=LOC117550267 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|B1WBH3|B1WBH3_XENTR,60.544,441,165,4,1,438,1,435,1.22e-178,513,B1WBH3,DNA-binding protein RFX2 OS=Xenopus tropicalis OX=8364 GN=vipr2 PE=2 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A671S5F6|A0A671S5F6_9TELE,59.039,437,169,7,8,438,4,436,1.89e-178,513,A0A671S5F6,Vasoactive intestinal polypeptide receptor 2-like OS=Sinocyclocheilus anshuiensis OX=1608454 GN=LOC107685459 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|M3ZWI2|M3ZWI2_XIPMA,58.670,421,163,5,22,438,22,435,2.08e-178,513,M3ZWI2,Uncharacterized protein OS=Xiphophorus maculatus OX=8083 GN=VIPR2 PE=3 SV=2
sp|P41587|VIPR2_HUMAN,tr|A0A3Q1GSY7|A0A3Q1GSY7_9TELE,59.145,421,163,5,22,438,22,437,4.74e-178,512,A0A3Q1GSY7,Vasoactive intestinal polypeptide receptor 2-like OS=Acanthochromis polyacanthus OX=80966 GN=VIPR2 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A674MZ90|A0A674MZ90_TAKRU,58.469,431,165,6,14,438,11,433,4.80e-178,511,A0A674MZ90,Uncharacterized protein OS=Takifugu rubripes OX=31033 GN=VIPR2 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A5N4DZR0|A0A5N4DZR0_CAMDR,86.364,286,39,0,153,438,14,299,4.81e-178,506,A0A5N4DZR0,Vasoactive intestinal polypeptide receptor 2 OS=Camelus dromedarius OX=9838 GN=Cadr_000008747 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A674ES51|A0A674ES51_SALTR,61.596,401,148,4,37,436,15,410,6.19e-178,510,A0A674ES51,Vasoactive intestinal polypeptide receptor 2-like OS=Salmo trutta OX=8032 GN=VIPR2 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A4W5P9U2|A0A4W5P9U2_9TELE,59.330,418,165,3,23,438,2,416,1.01e-177,510,A0A4W5P9U2,Vasoactive intestinal peptide receptor 2 OS=Hucho hucho OX=62062 GN=VIPR2 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|H3CRC2|H3CRC2_TETNG,58.756,434,170,6,8,438,5,432,1.10e-177,511,H3CRC2,Vasoactive intestinal peptide receptor 2 OS=Tetraodon nigroviridis OX=99883 GN=VIPR2 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|G3PZZ7|G3PZZ7_GASAC,63.660,388,136,4,51,438,1,383,2.00e-177,508,G3PZZ7,Vasoactive intestinal peptide receptor 2 OS=Gasterosteus aculeatus OX=69293 GN=VIPR2 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|V9KG85|V9KG85_CALMI,59.318,440,167,4,1,438,1,430,4.53e-177,509,V9KG85,Vasoactive intestinal polypeptide receptor 2 OS=Callorhinchus milii OX=7868 GN=VIPR2 PE=2 SV=1
sp|P41587|VIPR2_HUMAN,tr|F6WLY3|F6WLY3_XENTR,61.593,427,155,4,15,438,4,424,5.61e-177,508,F6WLY3,Transcription factor RFX3 OS=Xenopus tropicalis OX=8364 GN=rfx3 PE=3 SV=2
sp|P41587|VIPR2_HUMAN,tr|A0A670HSR2|A0A670HSR2_PODMU,78.233,317,68,1,122,438,8,323,5.91e-176,502,A0A670HSR2,G_PROTEIN_RECEP_F2_4 domain-containing protein OS=Podarcis muralis OX=64176 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A670HTL4|A0A670HTL4_PODMU,78.233,317,68,1,122,438,42,357,1.77e-175,502,A0A670HTL4,G_PROTEIN_RECEP_F2_4 domain-containing protein OS=Podarcis muralis OX=64176 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A6P6MAR0|A0A6P6MAR0_CARAU,57.834,434,175,6,8,437,11,440,1.05e-174,503,A0A6P6MAR0,vasoactive intestinal polypeptide receptor 2-like OS=Carassius auratus OX=7957 GN=LOC113066148 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A5N5KSG1|A0A5N5KSG1_PANHP,57.834,434,174,6,9,437,39,468,1.15e-174,504,A0A5N5KSG1,Uncharacterized protein OS=Pangasianodon hypophthalmus OX=310915 GN=PHYPO_G00130660 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A3P4LXW7|A0A3P4LXW7_GULGU,85.714,287,41,0,152,438,14,300,2.10e-174,497,A0A3P4LXW7,G_PROTEIN_RECEP_F2_4 domain-containing protein (Fragment) OS=Gulo gulo OX=48420 GN=BN2614_LOCUS2 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A4W5PGY5|A0A4W5PGY5_9TELE,62.371,388,138,4,51,438,26,405,3.03e-174,501,A0A4W5PGY5,Vasoactive intestinal peptide receptor 2 OS=Hucho hucho OX=62062 GN=VIPR2 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A670HSQ3|A0A670HSQ3_PODMU,69.542,371,102,4,71,438,48,410,8.54e-174,500,A0A670HSQ3,G_PROTEIN_RECEP_F2_4 domain-containing protein OS=Podarcis muralis OX=64176 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A4W4GA25|A0A4W4GA25_ELEEL,58.005,431,169,5,18,438,15,443,1.44e-173,501,A0A4W4GA25,Uncharacterized protein OS=Electrophorus electricus OX=8005 GN=vipr2 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A6P6JF02|A0A6P6JF02_CARAU,55.955,445,179,6,8,438,10,451,4.28e-173,500,A0A6P6JF02,vasoactive intestinal polypeptide receptor 2-like OS=Carassius auratus OX=7957 GN=LOC113042379 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|F1QSJ4|F1QSJ4_DANRE,57.931,435,176,5,8,438,10,441,9.40e-173,498,F1QSJ4,Vasoactive intestinal peptide receptor 2 OS=Danio rerio OX=7955 GN=vipr2 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A3Q3GBB1|A0A3Q3GBB1_9LABR,61.598,388,144,3,51,438,70,452,9.41e-173,499,A0A3Q3GBB1,Vasoactive intestinal peptide receptor 2 OS=Labrus bergylta OX=56723 GN=VIPR2 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A6P8QJ55|A0A6P8QJ55_GEOSA,64.247,372,128,4,11,381,20,387,1.71e-172,497,A0A6P8QJ55,vasoactive intestinal polypeptide receptor 2 isoform X3 OS=Geotrypetes seraphini OX=260995 GN=VIPR2 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A672S3P4|A0A672S3P4_SINGR,57.701,435,174,7,8,438,11,439,2.06e-171,495,A0A672S3P4,Vasoactive intestinal peptide receptor 2 OS=Sinocyclocheilus grahami OX=75366 GN=vipr2 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A673HZB3|A0A673HZB3_9TELE,58.065,434,171,8,10,438,11,438,1.90e-170,493,A0A673HZB3,Vasoactive intestinal polypeptide receptor 2-like OS=Sinocyclocheilus rhinocerous OX=307959 GN=LOC107729663 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A4Z2H1P2|A0A4Z2H1P2_9TELE,55.756,443,148,6,18,438,2,418,4.13e-170,491,A0A4Z2H1P2,Vasoactive intestinal polypeptide receptor 2 OS=Liparis tanakae OX=230148 GN=Vipr2_0 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A091RJV2|A0A091RJV2_9GRUI,76.875,320,74,0,119,438,1,320,8.45e-170,486,A0A091RJV2,Vasoactive intestinal polypeptide receptor 2 (Fragment) OS=Mesitornis unicolor OX=54374 GN=N332_05776 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A3B1J1G1|A0A3B1J1G1_ASTMX,60.714,392,147,4,51,438,24,412,8.65e-170,490,A0A3B1J1G1,Vasoactive intestinal peptide receptor 2 OS=Astyanax mexicanus OX=7994 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A094L722|A0A094L722_ANTCR,76.875,320,74,0,119,438,1,320,9.13e-170,486,A0A094L722,Vasoactive intestinal polypeptide receptor 2 (Fragment) OS=Antrostomus carolinensis OX=279965 GN=N321_07250 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A673HVT7|A0A673HVT7_9TELE,58.670,421,164,7,22,438,19,433,1.02e-169,490,A0A673HVT7,Vasoactive intestinal polypeptide receptor 2-like OS=Sinocyclocheilus rhinocerous OX=307959 GN=LOC107729663 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A091HXJ6|A0A091HXJ6_BUCRH,76.875,320,74,0,119,438,1,320,1.44e-169,486,A0A091HXJ6,Vasoactive intestinal polypeptide receptor 2 (Fragment) OS=Buceros rhinoceros silvestris OX=175836 GN=N320_09976 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A498NNZ0|A0A498NNZ0_LABRO,59.559,408,156,6,35,438,3,405,2.18e-169,488,A0A498NNZ0,Vasoactive intestinal polypeptide receptor 2-like protein OS=Labeo rohita OX=84645 GN=ROHU_004308 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A091LM82|A0A091LM82_CATAU,76.250,320,76,0,119,438,1,320,3.11e-169,485,A0A091LM82,Vasoactive intestinal polypeptide receptor 2 (Fragment) OS=Cathartes aura OX=43455 GN=N323_12855 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A087VM59|A0A087VM59_BALRE,76.562,320,75,0,119,438,1,320,5.25e-169,484,A0A087VM59,Vasoactive intestinal polypeptide receptor 2 (Fragment) OS=Balearica regulorum gibbericeps OX=100784 GN=N312_02617 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|W5KCM8|W5KCM8_ASTMX,60.000,395,149,4,51,438,17,409,2.40e-168,486,W5KCM8,Vasoactive intestinal peptide receptor 2 OS=Astyanax mexicanus OX=7994 PE=3 SV=2
sp|P41587|VIPR2_HUMAN,tr|A0A315W3E3|A0A315W3E3_GAMAF,55.830,446,161,6,22,438,459,897,5.83e-168,502,A0A315W3E3,Uncharacterized protein OS=Gambusia affinis OX=33528 GN=CCH79_00009768 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A093F571|A0A093F571_GAVST,76.730,318,74,0,121,438,1,318,8.79e-167,478,A0A093F571,Vasoactive intestinal polypeptide receptor 2 (Fragment) OS=Gavia stellata OX=37040 GN=N328_11020 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A674ETW9|A0A674ETW9_SALTR,59.158,404,152,6,37,436,32,426,1.16e-165,480,A0A674ETW9,Vasoactive intestinal polypeptide receptor 2-like OS=Salmo trutta OX=8032 GN=VIPR2 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A484CUW3|A0A484CUW3_PERFV,65.537,354,117,3,85,438,3,351,1.50e-165,477,A0A484CUW3,G_PROTEIN_RECEP_F2_4 domain-containing protein OS=Perca flavescens OX=8167 GN=EPR50_G00131770 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A6J2VDA0|A0A6J2VDA0_CHACN,57.512,426,161,8,22,438,21,435,4.66e-165,482,A0A6J2VDA0,vasoactive intestinal polypeptide receptor 2-like OS=Chanos chanos OX=29144 GN=LOC115811207 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A4W3GL26|A0A4W3GL26_CALMI,56.591,440,175,5,1,438,1,426,1.12e-164,478,A0A4W3GL26,Uncharacterized protein OS=Callorhinchus milii OX=7868 GN=VIPR2 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A3Q3WJD5|A0A3Q3WJD5_MOLML,60.459,392,144,5,49,438,50,432,1.33e-164,478,A0A3Q3WJD5,Vasoactive intestinal peptide receptor 2 OS=Mola mola OX=94237 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A1S3NHH6|A0A1S3NHH6_SALSA,57.210,423,173,5,18,436,20,438,1.79e-163,475,A0A1S3NHH6,vasoactive intestinal polypeptide receptor 2-like OS=Salmo salar OX=8030 GN=LOC106579482 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A6P6P680|A0A6P6P680_CARAU,58.500,400,150,5,52,438,1,397,2.54e-163,473,A0A6P6P680,vasoactive intestinal polypeptide receptor 2-like OS=Carassius auratus OX=7957 GN=LOC113095092 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A3Q3LYJ1|A0A3Q3LYJ1_9TELE,60.668,389,134,6,51,438,11,381,1.12e-162,471,A0A3Q3LYJ1,Vasoactive intestinal peptide receptor 2 OS=Mastacembelus armatus OX=205130 PE=3 SV=2
sp|P41587|VIPR2_HUMAN,tr|H2LMX1|H2LMX1_ORYLA,59.794,388,133,4,51,438,45,409,1.39e-162,471,H2LMX1,Uncharacterized protein OS=Oryzias latipes OX=8090 GN=LOC101155464 PE=3 SV=2
sp|P41587|VIPR2_HUMAN,tr|A0A6G1Q8U6|A0A6G1Q8U6_9TELE,55.479,438,159,6,18,438,100,518,2.65e-162,476,A0A6G1Q8U6,Vasoactive intestinal polypeptide receptor 2 OS=Channa argus OX=215402 GN=EXN66_Car014273 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A4W4GDE5|A0A4W4GDE5_ELEEL,57.343,429,170,6,18,438,17,440,3.56e-162,471,A0A4W4GDE5,Uncharacterized protein OS=Electrophorus electricus OX=8005 GN=vipr2 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A0R4IJV3|A0A0R4IJV3_DANRE,57.011,435,168,7,8,438,10,429,4.12e-162,471,A0A0R4IJV3,Vasoactive intestinal peptide receptor 2 OS=Danio rerio OX=7955 GN=vipr2 PE=4 SV=2
sp|P41587|VIPR2_HUMAN,tr|A0A3P9Q3T6|A0A3P9Q3T6_POERE,56.355,417,168,6,22,438,5,407,6.43e-162,469,A0A3P9Q3T6,Vasoactive intestinal peptide receptor 2 OS=Poecilia reticulata OX=8081 GN=VIPR2 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A674B184|A0A674B184_SALTR,56.368,424,179,4,16,436,18,438,8.35e-162,471,A0A674B184,Vasoactive intestinal polypeptide receptor 2-like OS=Salmo trutta OX=8032 GN=LOC115151817 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A673MZL1|A0A673MZL1_9TELE,55.102,441,174,9,8,438,4,430,8.56e-162,470,A0A673MZL1,Vasoactive intestinal polypeptide receptor 2-like OS=Sinocyclocheilus rhinocerous OX=307959 GN=LOC107725846 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A6Q2YNN6|A0A6Q2YNN6_ESOLU,55.634,426,183,4,14,436,14,436,9.69e-162,470,A0A6Q2YNN6,Vasoactive intestinal polypeptide receptor 2 OS=Esox lucius OX=8010 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A671Z2B0|A0A671Z2B0_SPAAU,61.399,386,124,5,53,438,43,403,1.02e-161,469,A0A671Z2B0,Vasoactive intestinal polypeptide receptor 2-like OS=Sparus aurata OX=8175 GN=VIPR2 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A674ALV7|A0A674ALV7_SALTR,58.049,410,158,7,36,438,44,446,1.73e-161,470,A0A674ALV7,Vasoactive intestinal polypeptide receptor 2-like OS=Salmo trutta OX=8032 GN=LOC115169812 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A484C7H5|A0A484C7H5_PERFV,55.660,424,183,4,18,438,20,441,6.87e-161,468,A0A484C7H5,Uncharacterized protein OS=Perca flavescens OX=8167 GN=EPR50_G00227100 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A3P8ZY90|A0A3P8ZY90_ESOLU,55.687,422,181,4,18,436,31,449,7.29e-161,469,A0A3P8ZY90,Vasoactive intestinal polypeptide receptor 2 OS=Esox lucius OX=8010 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A3Q3MF83|A0A3Q3MF83_9TELE,59.897,389,133,6,51,438,20,386,1.35e-160,466,A0A3Q3MF83,Vasoactive intestinal peptide receptor 2 OS=Mastacembelus armatus OX=205130 PE=3 SV=2
sp|P41587|VIPR2_HUMAN,tr|A0A673AE45|A0A673AE45_9TELE,60.052,388,120,4,51,438,24,376,2.71e-160,464,A0A673AE45,Vasoactive intestinal peptide receptor 2 OS=Sphaeramia orbicularis OX=375764 GN=VIPR2 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A803JTJ0|A0A803JTJ0_XENTR,57.078,438,149,4,1,438,1,399,3.05e-160,465,A0A803JTJ0,Vasoactive intestinal peptide receptor 2 OS=Xenopus tropicalis OX=8364 GN=vipr2 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A674ALH0|A0A674ALH0_SALTR,59.536,388,137,5,51,438,49,416,9.10e-160,464,A0A674ALH0,Vasoactive intestinal polypeptide receptor 2-like OS=Salmo trutta OX=8032 GN=LOC115169812 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A6A5DVS7|A0A6A5DVS7_PERFL,55.425,424,184,4,18,438,20,441,1.81e-159,465,A0A6A5DVS7,Uncharacterized protein OS=Perca fluviatilis OX=8168 GN=PFLUV_G00258640 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A3Q1ART2|A0A3Q1ART2_AMPOC,55.269,427,182,5,18,438,17,440,2.20e-159,464,A0A3Q1ART2,Vasoactive intestinal polypeptide receptor 2-like OS=Amphiprion ocellaris OX=80972 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A4W5LJ24|A0A4W5LJ24_9TELE,59.383,389,137,6,50,438,17,384,4.51e-159,461,A0A4W5LJ24,Uncharacterized protein OS=Hucho hucho OX=62062 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A3P8SIF5|A0A3P8SIF5_AMPPE,56.627,415,174,4,27,438,1,412,1.66e-158,461,A0A3P8SIF5,Vasoactive intestinal peptide receptor 2 OS=Amphiprion percula OX=161767 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A3Q2WLE2|A0A3Q2WLE2_HAPBU,59.794,388,134,5,51,438,60,425,1.88e-158,461,A0A3Q2WLE2,Vasoactive intestinal peptide receptor 2 OS=Haplochromis burtoni OX=8153 GN=VIPR2 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A668AK59|A0A668AK59_9TELE,59.278,388,151,4,51,438,35,415,6.40e-158,460,A0A668AK59,Vasoactive intestinal peptide receptor 2 OS=Myripristis murdjan OX=586833 GN=VIPR2 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A4W6G5G6|A0A4W6G5G6_LATCA,54.023,435,189,5,14,438,10,443,1.87e-157,460,A0A4W6G5G6,Vasoactive intestinal polypeptide receptor 2-like OS=Lates calcarifer OX=8187 GN=LOC108885058 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A060W5S4|A0A060W5S4_ONCMY,59.530,383,122,5,82,438,2,377,2.72e-157,457,A0A060W5S4,G_PROTEIN_RECEP_F2_4 domain-containing protein OS=Oncorhynchus mykiss OX=8022 GN=GSONMT00067522001 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A674MD54|A0A674MD54_TAKRU,59.079,391,143,6,48,438,46,419,3.69e-157,458,A0A674MD54,Uncharacterized protein OS=Takifugu rubripes OX=31033 GN=VIPR2 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A668U2L5|A0A668U2L5_OREAU,60.000,390,130,6,51,438,6,371,5.07e-157,456,A0A668U2L5,Vasoactive intestinal peptide receptor 2 OS=Oreochromis aureus OX=47969 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A6Q2WPZ3|A0A6Q2WPZ3_ESOLU,54.587,436,178,7,9,436,9,432,9.47e-157,457,A0A6Q2WPZ3,Vasoactive intestinal polypeptide receptor 2 OS=Esox lucius OX=8010 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A668U562|A0A668U562_OREAU,59.057,403,139,6,38,438,46,424,3.23e-156,456,A0A668U562,Vasoactive intestinal peptide receptor 2 OS=Oreochromis aureus OX=47969 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A671WFF4|A0A671WFF4_SPAAU,54.481,424,188,4,18,438,20,441,3.47e-156,456,A0A671WFF4,Vasoactive intestinal polypeptide receptor 2-like OS=Sparus aurata OX=8175 GN=LOC115569556 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A6Q2XVP0|A0A6Q2XVP0_ESOLU,52.993,451,182,7,6,436,6,446,3.66e-156,457,A0A6Q2XVP0,Vasoactive intestinal polypeptide receptor 2 OS=Esox lucius OX=8010 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A674ETM2|A0A674ETM2_SALTR,57.750,400,132,5,37,436,15,377,4.67e-156,454,A0A674ETM2,Vasoactive intestinal polypeptide receptor 2-like OS=Salmo trutta OX=8032 GN=VIPR2 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A668U2N5|A0A668U2N5_OREAU,59.794,388,128,6,51,438,40,399,5.21e-156,454,A0A668U2N5,Vasoactive intestinal peptide receptor 2 OS=Oreochromis aureus OX=47969 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A672S3F6|A0A672S3F6_SINGR,56.000,425,170,9,18,438,18,429,6.48e-156,455,A0A672S3F6,Vasoactive intestinal peptide receptor 2 OS=Sinocyclocheilus grahami OX=75366 GN=vipr2 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|H2SPB9|H2SPB9_TAKRU,59.481,385,139,6,54,438,19,386,1.16e-155,453,H2SPB9,Uncharacterized protein OS=Takifugu rubripes OX=31033 GN=VIPR2 PE=3 SV=3
sp|P41587|VIPR2_HUMAN,tr|A0A668U2J3|A0A668U2J3_OREAU,60.000,380,127,5,59,438,5,359,2.48e-155,451,A0A668U2J3,Vasoactive intestinal peptide receptor 2 OS=Oreochromis aureus OX=47969 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A4W5LIY7|A0A4W5LIY7_9TELE,58.462,390,138,6,51,438,39,406,2.54e-155,453,A0A4W5LIY7,Uncharacterized protein OS=Hucho hucho OX=62062 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A3Q3CP48|A0A3Q3CP48_HAPBU,59.033,393,135,6,51,438,60,431,2.83e-155,454,A0A3Q3CP48,Vasoactive intestinal peptide receptor 2 OS=Haplochromis burtoni OX=8153 GN=VIPR2 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A3Q2VBH9|A0A3Q2VBH9_HAPBU,59.694,392,129,6,51,438,39,405,2.89e-155,452,A0A3Q2VBH9,Vasoactive intestinal peptide receptor 2 OS=Haplochromis burtoni OX=8153 GN=VIPR2 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A4W5LIS5|A0A4W5LIS5_9TELE,59.079,391,144,7,51,438,45,422,1.14e-154,452,A0A4W5LIS5,Uncharacterized protein OS=Hucho hucho OX=62062 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A672S3E4|A0A672S3E4_SINGR,53.159,459,172,10,8,438,9,452,4.86e-154,451,A0A672S3E4,Vasoactive intestinal peptide receptor 2 OS=Sinocyclocheilus grahami OX=75366 GN=vipr2 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A672GCW1|A0A672GCW1_SALFA,54.808,416,181,4,26,438,1,412,5.57e-154,450,A0A672GCW1,Vasoactive intestinal peptide receptor 2 OS=Salarias fasciatus OX=181472 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A672HKP3|A0A672HKP3_SALFA,55.227,440,168,9,1,438,1,413,6.86e-154,449,A0A672HKP3,Uncharacterized protein OS=Salarias fasciatus OX=181472 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A1S3GPI3|A0A1S3GPI3_DIPOR,51.936,439,201,5,1,432,1,436,1.85e-153,450,A0A1S3GPI3,pituitary adenylate cyclase-activating polypeptide type I receptor isoform X4 OS=Dipodomys ordii OX=10020 GN=Adcyap1r1 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A668U2J9|A0A668U2J9_OREAU,58.763,388,137,5,51,438,25,389,4.63e-153,447,A0A668U2J9,Vasoactive intestinal peptide receptor 2 OS=Oreochromis aureus OX=47969 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A3Q1FZT2|A0A3Q1FZT2_9TELE,53.938,419,187,3,23,438,25,440,5.44e-153,448,A0A3Q1FZT2,Vasoactive intestinal polypeptide receptor 2-like OS=Acanthochromis polyacanthus OX=80966 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A663M7T9|A0A663M7T9_ATHCN,53.494,415,185,4,20,429,3,414,6.03e-153,447,A0A663M7T9,ADCYAP receptor type I OS=Athene cunicularia OX=194338 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A3Q1EM08|A0A3Q1EM08_9TELE,53.938,419,187,3,23,438,36,451,1.20e-152,448,A0A3Q1EM08,Vasoactive intestinal polypeptide receptor 2-like OS=Acanthochromis polyacanthus OX=80966 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A093IRF4|A0A093IRF4_EURHL,77.509,289,65,0,150,438,5,293,4.30e-152,440,A0A093IRF4,Vasoactive intestinal polypeptide receptor 2 (Fragment) OS=Eurypyga helias OX=54383 GN=N326_03070 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A091IRJ2|A0A091IRJ2_CALAN,77.163,289,66,0,150,438,5,293,5.30e-152,440,A0A091IRJ2,Vasoactive intestinal polypeptide receptor 2 (Fragment) OS=Calypte anna OX=9244 GN=N300_04205 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A665XFE8|A0A665XFE8_ECHNA,59.640,389,145,6,51,438,11,388,5.43e-152,444,A0A665XFE8,Vasoactive intestinal peptide receptor 2 OS=Echeneis naucrates OX=173247 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A091LVZ2|A0A091LVZ2_CARIC,77.163,289,66,0,150,438,5,293,7.52e-152,440,A0A091LVZ2,Vasoactive intestinal polypeptide receptor 2 (Fragment) OS=Cariama cristata OX=54380 GN=N322_10687 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A0Q3XAN0|A0A0Q3XAN0_AMAAE,54.567,416,179,6,10,420,12,422,1.22e-151,445,A0A0Q3XAN0,Vasoactive intestinal polypeptide receptor-like protein OS=Amazona aestiva OX=12930 GN=AAES_01826 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A671G0I8|A0A671G0I8_RHIFE,51.835,436,200,5,1,429,1,433,1.27e-151,445,A0A671G0I8,ADCYAP receptor type I OS=Rhinolophus ferrumequinum OX=59479 GN=ADCYAP1R1 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A6Q2WXJ6|A0A6Q2WXJ6_ESOLU,54.739,422,184,4,18,436,20,437,2.63e-151,444,A0A6Q2WXJ6,Vasoactive intestinal polypeptide receptor 2 OS=Esox lucius OX=8010 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A673UKK4|A0A673UKK4_SURSU,50.682,440,199,6,1,429,1,433,2.84e-151,444,A0A673UKK4,ADCYAP receptor type I OS=Suricata suricatta OX=37032 GN=ADCYAP1R1 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A672TPR7|A0A672TPR7_STRHB,53.538,424,184,6,6,420,3,422,3.80e-151,444,A0A672TPR7,Vasoactive intestinal peptide receptor 1 OS=Strigops habroptila OX=2489341 GN=VIPR1 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A665XEQ4|A0A665XEQ4_ECHNA,59.897,389,141,5,51,438,11,385,4.29e-151,441,A0A665XEQ4,Vasoactive intestinal peptide receptor 2 OS=Echeneis naucrates OX=173247 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A3Q1JRZ0|A0A3Q1JRZ0_ANATE,59.278,388,146,4,51,438,23,398,5.41e-151,442,A0A3Q1JRZ0,Uncharacterized protein OS=Anabas testudineus OX=64144 PE=4 SV=2
sp|P41587|VIPR2_HUMAN,tr|A0A3Q2DB89|A0A3Q2DB89_CYPVA,57.841,389,154,6,51,438,49,428,6.34e-151,442,A0A3Q2DB89,Vasoactive intestinal polypeptide receptor 2-like OS=Cyprinodon variegatus OX=28743 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A3P8UH51|A0A3P8UH51_CYNSE,52.055,438,200,6,10,438,9,445,6.48e-151,443,A0A3P8UH51,Vasoactive intestinal polypeptide receptor 2-like OS=Cynoglossus semilaevis OX=244447 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A6P6ICB5|A0A6P6ICB5_PUMCO,50.909,440,198,6,1,429,1,433,6.64e-151,443,A0A6P6ICB5,pituitary adenylate cyclase-activating polypeptide type I receptor isoform X2 OS=Puma concolor OX=9696 GN=ADCYAP1R1 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A5F5Y6X4|A0A5F5Y6X4_FELCA,50.909,440,198,6,1,429,1,433,6.64e-151,443,A0A5F5Y6X4,ADCYAP receptor type I OS=Felis catus OX=9685 GN=ADCYAP1R1 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A1S3GQQ1|A0A1S3GQQ1_DIPOR,49.783,460,200,5,1,432,1,457,8.07e-151,444,A0A1S3GQQ1,pituitary adenylate cyclase-activating polypeptide type I receptor isoform X3 OS=Dipodomys ordii OX=10020 GN=Adcyap1r1 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A2K5EIX5|A0A2K5EIX5_AOTNA,51.852,432,189,7,10,429,9,433,1.06e-150,442,A0A2K5EIX5,ADCYAP receptor type I OS=Aotus nancymaae OX=37293 GN=ADCYAP1R1 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A4W5QD14|A0A4W5QD14_9TELE,51.972,431,191,7,8,429,6,429,1.19e-150,442,A0A4W5QD14,Adenylate cyclase activating polypeptide 1a (pituitary) receptor type I OS=Hucho hucho OX=62062 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A1V4KL97|A0A1V4KL97_PATFA,49.784,464,191,6,1,429,1,457,1.32e-150,443,A0A1V4KL97,Pituitary adenylate cyclase-activating polypeptide type I receptor isoform C OS=Patagioenas fasciata monilis OX=372326 GN=ADCYAP1R1 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A2Y9T4M6|A0A2Y9T4M6_PHYMC,52.619,420,181,6,21,429,21,433,1.93e-150,442,A0A2Y9T4M6,pituitary adenylate cyclase-activating polypeptide type I receptor isoform X4 OS=Physeter macrocephalus OX=9755 GN=ADCYAP1R1 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A671XBB0|A0A671XBB0_SPAAU,52.153,418,184,5,31,435,31,445,2.04e-150,442,A0A671XBB0,Pituitary adenylate cyclase-activating polypeptide type I receptor-like OS=Sparus aurata OX=8175 GN=LOC115591282 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A3Q3MEB4|A0A3Q3MEB4_9TELE,55.474,411,178,4,31,438,1,409,2.30e-150,440,A0A3Q3MEB4,Vasoactive intestinal polypeptide receptor 2-like OS=Mastacembelus armatus OX=205130 PE=4 SV=2
sp|P41587|VIPR2_HUMAN,tr|A0A671XBB6|A0A671XBB6_SPAAU,52.153,418,184,5,31,435,25,439,2.58e-150,441,A0A671XBB6,Pituitary adenylate cyclase-activating polypeptide type I receptor-like OS=Sparus aurata OX=8175 GN=LOC115591282 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A2U3WX17|A0A2U3WX17_ODORO,51.481,439,198,6,1,429,1,434,3.19e-150,441,A0A2U3WX17,pituitary adenylate cyclase-activating polypeptide type I receptor isoform X3 OS=Odobenus rosmarus divergens OX=9708 GN=ADCYAP1R1 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|E9Q3E8|E9Q3E8_MOUSE,52.246,423,192,5,20,435,20,439,3.22e-150,441,E9Q3E8,Pituitary adenylate cyclase-activating polypeptide type I receptor OS=Mus musculus OX=10090 GN=Adcyap1r1 PE=1 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A671XHR5|A0A671XHR5_SPAAU,52.153,418,184,5,31,435,31,445,3.48e-150,441,A0A671XHR5,Pituitary adenylate cyclase-activating polypeptide type I receptor-like OS=Sparus aurata OX=8175 GN=LOC115591282 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A2K6DXZ3|A0A2K6DXZ3_MACNE,50.909,440,198,6,1,429,1,433,3.56e-150,441,A0A2K6DXZ3,ADCYAP receptor type I OS=Macaca nemestrina OX=9545 GN=ADCYAP1R1 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A1D5QCN0|A0A1D5QCN0_MACMU,50.909,440,198,6,1,429,1,433,3.56e-150,441,A0A1D5QCN0,ADCYAP receptor type I OS=Macaca mulatta OX=9544 GN=ADCYAP1R1 PE=4 SV=2
sp|P41587|VIPR2_HUMAN,tr|A0A7N5JZZ7|A0A7N5JZZ7_AILME,51.253,439,199,6,1,429,1,434,4.10e-150,441,A0A7N5JZZ7,ADCYAP receptor type I OS=Ailuropoda melanoleuca OX=9646 GN=ADCYAP1R1 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A663M8F2|A0A663M8F2_ATHCN,52.225,427,186,5,18,429,2,425,4.29e-150,441,A0A663M8F2,ADCYAP receptor type I OS=Athene cunicularia OX=194338 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A5F4CBF4|A0A5F4CBF4_CANLF,51.259,437,202,5,1,429,1,434,5.04e-150,441,A0A5F4CBF4,ADCYAP receptor type I OS=Canis lupus familiaris OX=9615 GN=ADCYAP1R1 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|V8P3Z7|V8P3Z7_OPHHA,59.900,399,120,4,40,438,52,410,5.34e-150,439,V8P3Z7,Vasoactive intestinal polypeptide receptor 2 (Fragment) OS=Ophiophagus hannah OX=8665 GN=VIPR2 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A2K6SQJ7|A0A2K6SQJ7_SAIBB,52.133,422,184,6,19,429,19,433,5.93e-150,441,A0A2K6SQJ7,ADCYAP receptor type I OS=Saimiri boliviensis boliviensis OX=39432 GN=ADCYAP1R1 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|F6Q7I3|F6Q7I3_PIG,53.012,415,185,5,22,429,22,433,6.40e-150,441,F6Q7I3,ADCYAP receptor type I OS=Sus scrofa OX=9823 GN=ADCYAP1R1 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A2Y9H7Q1|A0A2Y9H7Q1_NEOSC,51.025,439,200,6,1,429,1,434,7.23e-150,441,A0A2Y9H7Q1,pituitary adenylate cyclase-activating polypeptide type I receptor isoform X2 OS=Neomonachus schauinslandi OX=29088 GN=ADCYAP1R1 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A665WBM9|A0A665WBM9_ECHNA,51.196,418,188,5,31,435,17,431,7.26e-150,440,A0A665WBM9,Adenylate cyclase activating polypeptide 1a (pituitary) receptor type I OS=Echeneis naucrates OX=173247 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A665WC14|A0A665WC14_ECHNA,51.196,418,188,5,31,435,17,431,7.51e-150,440,A0A665WC14,Adenylate cyclase activating polypeptide 1a (pituitary) receptor type I OS=Echeneis naucrates OX=173247 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A2R8QQ14|A0A2R8QQ14_DANRE,62.817,355,126,4,87,438,69,420,8.39e-150,439,A0A2R8QQ14,Vasoactive intestinal peptide receptor 2 OS=Danio rerio OX=7955 GN=vipr2 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A2I3N5Q0|A0A2I3N5Q0_PAPAN,50.797,439,199,6,1,429,1,432,8.49e-150,440,A0A2I3N5Q0,ADCYAP receptor type I OS=Papio anubis OX=9555 GN=ADCYAP1R1 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A672HNC6|A0A672HNC6_SALFA,52.163,416,185,5,31,435,29,441,9.87e-150,440,A0A672HNC6,Adenylate cyclase activating polypeptide 1a (pituitary) receptor type I OS=Salarias fasciatus OX=181472 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A672HN44|A0A672HN44_SALFA,52.038,417,185,5,31,435,35,448,1.04e-149,440,A0A672HN44,Adenylate cyclase activating polypeptide 1a (pituitary) receptor type I OS=Salarias fasciatus OX=181472 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A2K6M084|A0A2K6M084_RHIBE,52.745,419,180,6,22,429,22,433,1.09e-149,440,A0A2K6M084,Uncharacterized protein OS=Rhinopithecus bieti OX=61621 GN=ADCYAP1R1 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A667Z029|A0A667Z029_9TELE,56.888,392,150,4,51,438,18,394,1.26e-149,438,A0A667Z029,Vasoactive intestinal peptide receptor 2 OS=Myripristis murdjan OX=586833 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A672HP83|A0A672HP83_SALFA,52.404,416,180,6,31,435,20,428,1.45e-149,439,A0A672HP83,Adenylate cyclase activating polypeptide 1a (pituitary) receptor type I OS=Salarias fasciatus OX=181472 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A3Q7P588|A0A3Q7P588_CALUR,51.253,439,199,6,1,429,1,434,1.50e-149,440,A0A3Q7P588,pituitary adenylate cyclase-activating polypeptide type I receptor isoform X3 OS=Callorhinus ursinus OX=34884 GN=ADCYAP1R1 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A2K6QPF6|A0A2K6QPF6_RHIRO,52.257,421,183,6,20,429,12,425,1.60e-149,439,A0A2K6QPF6,Uncharacterized protein OS=Rhinopithecus roxellana OX=61622 GN=ADCYAP1R1 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A663M4U4|A0A663M4U4_ATHCN,54.300,407,176,6,19,420,19,420,1.74e-149,439,A0A663M4U4,Vasoactive intestinal peptide receptor 1 OS=Athene cunicularia OX=194338 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|G3NP79|G3NP79_GASAC,51.675,418,189,4,31,435,33,450,2.00e-149,440,G3NP79,Adenylate cyclase activating polypeptide 1a (pituitary) receptor type I OS=Gasterosteus aculeatus OX=69293 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A6J2HYR4|A0A6J2HYR4_9PASS,54.436,417,179,7,9,420,25,435,2.53e-149,439,A0A6J2HYR4,vasoactive intestinal polypeptide receptor OS=Pipra filicauda OX=649802 GN=LOC113996142 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A4W2FRZ4|A0A4W2FRZ4_BOBOX,51.781,421,185,6,20,429,20,433,2.64e-149,439,A0A4W2FRZ4,ADCYAP receptor type I OS=Bos indicus x Bos taurus OX=30522 GN=ADCYAP1R1 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A1U7SZR5|A0A1U7SZR5_CARSF,52.381,420,182,6,21,429,21,433,2.73e-149,439,A0A1U7SZR5,pituitary adenylate cyclase-activating polypeptide type I receptor isoform X5 OS=Carlito syrichta OX=1868482 GN=ADCYAP1R1 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A2K5Q9E6|A0A2K5Q9E6_CEBIM,52.506,419,181,6,22,429,22,433,2.76e-149,439,A0A2K5Q9E6,ADCYAP receptor type I OS=Cebus imitator OX=2715852 GN=ADCYAP1R1 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A672HK72|A0A672HK72_SALFA,57.538,398,161,5,41,438,50,439,3.08e-149,439,A0A672HK72,Uncharacterized protein OS=Salarias fasciatus OX=181472 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A2K5XNY0|A0A2K5XNY0_MANLE,50.569,439,200,6,1,429,1,432,3.21e-149,439,A0A2K5XNY0,ADCYAP receptor type I OS=Mandrillus leucophaeus OX=9568 GN=ADCYAP1R1 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A2I3SC74|A0A2I3SC74_PANTR,52.506,419,181,6,22,429,22,433,3.25e-149,439,A0A2I3SC74,ADCYAP receptor type I OS=Pan troglodytes OX=9598 GN=ADCYAP1R1 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A2I2ZBZ5|A0A2I2ZBZ5_GORGO,52.506,419,181,6,22,429,22,433,3.25e-149,439,A0A2I2ZBZ5,ADCYAP receptor type I OS=Gorilla gorilla gorilla OX=9595 GN=ADCYAP1R1 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A093Q6F1|A0A093Q6F1_9PASS,60.506,395,107,7,51,438,1,353,3.36e-149,435,A0A093Q6F1,Vasoactive intestinal polypeptide receptor 2 (Fragment) OS=Manacus vitellinus OX=328815 GN=N305_14670 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A286XED5|A0A286XED5_CAVPO,51.174,426,190,6,21,435,21,439,3.58e-149,439,A0A286XED5,Uncharacterized protein OS=Cavia porcellus OX=10141 GN=ADCYAP1R1 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A2R9A985|A0A2R9A985_PANPA,52.506,419,181,6,22,429,22,433,3.78e-149,439,A0A2R9A985,ADCYAP receptor type I OS=Pan paniscus OX=9597 GN=ADCYAP1R1 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A2K5M347|A0A2K5M347_CERAT,50.569,439,200,6,1,429,1,432,4.03e-149,439,A0A2K5M347,ADCYAP receptor type I OS=Cercocebus atys OX=9531 GN=ADCYAP1R1 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A665WC46|A0A665WC46_ECHNA,49.111,450,204,8,1,435,5,444,4.41e-149,439,A0A665WC46,Adenylate cyclase activating polypeptide 1a (pituitary) receptor type I OS=Echeneis naucrates OX=173247 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A6I9LYJ1|A0A6I9LYJ1_PERMB,49.351,462,203,5,2,435,7,465,4.76e-149,439,A0A6I9LYJ1,pituitary adenylate cyclase-activating polypeptide type I receptor isoform X3 OS=Peromyscus maniculatus bairdii OX=230844 GN=Adcyap1r1 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|U3JDS0|U3JDS0_FICAL,50.554,451,181,6,14,429,14,457,4.86e-149,439,U3JDS0,ADCYAP receptor type I OS=Ficedula albicollis OX=59894 GN=ADCYAP1R1 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A4W5QD32|A0A4W5QD32_9TELE,53.056,409,179,5,31,429,31,436,5.09e-149,439,A0A4W5QD32,Adenylate cyclase activating polypeptide 1a (pituitary) receptor type I OS=Hucho hucho OX=62062 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A674BTA7|A0A674BTA7_SALTR,53.056,409,179,5,31,429,30,435,5.37e-149,438,A0A674BTA7,Pituitary adenylate cyclase-activating polypeptide type I receptor-like OS=Salmo trutta OX=8032 GN=LOC115158670 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A671G062|A0A671G062_RHIFE,49.672,457,199,5,1,429,1,454,5.71e-149,439,A0A671G062,ADCYAP receptor type I OS=Rhinolophus ferrumequinum OX=59479 GN=ADCYAP1R1 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A1S3KJL8|A0A1S3KJL8_SALSA,53.056,409,179,5,31,429,30,435,6.90e-149,438,A0A1S3KJL8,pituitary adenylate cyclase-activating polypeptide type I receptor isoform X2 OS=Salmo salar OX=8030 GN=adcyap1r1 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A670YSU0|A0A670YSU0_PSETE,51.415,424,184,7,20,429,4,419,7.00e-149,437,A0A670YSU0,ADCYAP receptor type I OS=Pseudonaja textilis OX=8673 GN=ADCYAP1R1 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A674GEY8|A0A674GEY8_TAEGU,50.554,451,181,6,14,429,14,457,7.11e-149,439,A0A674GEY8,Uncharacterized protein OS=Taeniopygia guttata OX=59729 GN=ADCYAP1R1 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A2K6QPB5|A0A2K6QPB5_RHIRO,52.506,419,181,6,22,429,22,433,7.43e-149,438,A0A2K6QPB5,Uncharacterized protein OS=Rhinopithecus roxellana OX=61622 GN=ADCYAP1R1 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A674BTE1|A0A674BTE1_SALTR,53.317,407,179,5,31,429,27,430,8.00e-149,438,A0A674BTE1,Pituitary adenylate cyclase-activating polypeptide type I receptor-like OS=Salmo trutta OX=8032 GN=LOC115158670 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A3Q2V7H5|A0A3Q2V7H5_HAPBU,51.923,416,186,5,31,435,31,443,8.01e-149,438,A0A3Q2V7H5,Pituitary adenylate cyclase-activating polypeptide type I receptor-like OS=Haplochromis burtoni OX=8153 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A3B1K5Z4|A0A3B1K5Z4_ASTMX,51.054,427,190,6,21,435,24,443,8.74e-149,438,A0A3B1K5Z4,Uncharacterized protein OS=Astyanax mexicanus OX=7994 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A674BT88|A0A674BT88_SALTR,53.056,409,179,5,31,429,20,425,9.57e-149,437,A0A674BT88,Pituitary adenylate cyclase-activating polypeptide type I receptor-like OS=Salmo trutta OX=8032 GN=LOC115158670 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A2K6M088|A0A2K6M088_RHIBE,51.034,435,181,6,20,429,12,439,9.71e-149,438,A0A2K6M088,Uncharacterized protein OS=Rhinopithecus bieti OX=61621 GN=ADCYAP1R1 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|U3INT3|U3INT3_ANAPP,50.000,456,186,6,9,429,9,457,1.10e-148,438,U3INT3,ADCYAP receptor type I OS=Anas platyrhynchos platyrhynchos OX=8840 GN=ADCYAP1R1 PE=4 SV=2
sp|P41587|VIPR2_HUMAN,tr|A0A3Q2C6C0|A0A3Q2C6C0_CYPVA,51.442,416,188,5,31,435,35,447,1.26e-148,437,A0A3Q2C6C0,Pituitary adenylate cyclase-activating polypeptide type I receptor-like OS=Cyprinodon variegatus OX=28743 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A5N5PZ45|A0A5N5PZ45_PANHP,50.342,439,199,6,9,435,12,443,1.27e-148,437,A0A5N5PZ45,Uncharacterized protein OS=Pangasianodon hypophthalmus OX=310915 GN=PHYPO_G00106320 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A3P9CLB5|A0A3P9CLB5_9CICH,52.058,413,184,5,34,435,2,411,1.58e-148,436,A0A3P9CLB5,Pituitary adenylate cyclase-activating polypeptide type I receptor OS=Maylandia zebra OX=106582 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A3Q2DB66|A0A3Q2DB66_CYPVA,55.750,400,159,6,40,438,3,385,1.69e-148,435,A0A3Q2DB66,Vasoactive intestinal polypeptide receptor 2-like OS=Cyprinodon variegatus OX=28743 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A6P3EKP6|A0A6P3EKP6_OCTDE,50.939,426,191,6,21,435,21,439,1.70e-148,437,A0A6P3EKP6,pituitary adenylate cyclase-activating polypeptide type I receptor isoform X4 OS=Octodon degus OX=10160 GN=Adcyap1r1 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A6P7IB25|A0A6P7IB25_9TELE,51.566,415,188,4,31,435,31,442,1.72e-148,437,A0A6P7IB25,pituitary adenylate cyclase-activating polypeptide type I receptor-like isoform X2 OS=Parambassis ranga OX=210632 GN=LOC114434834 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A674BTA8|A0A674BTA8_SALTR,53.056,409,179,5,31,429,27,432,1.74e-148,437,A0A674BTA8,Pituitary adenylate cyclase-activating polypeptide type I receptor-like OS=Salmo trutta OX=8032 GN=LOC115158670 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A672TSA3|A0A672TSA3_STRHB,49.781,456,187,6,9,429,9,457,2.02e-148,438,A0A672TSA3,ADCYAP receptor type I OS=Strigops habroptila OX=2489341 GN=ADCYAP1R1 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A2K6SQK7|A0A2K6SQK7_SAIBB,50.000,450,192,7,5,429,1,442,2.16e-148,437,A0A2K6SQK7,ADCYAP receptor type I OS=Saimiri boliviensis boliviensis OX=39432 GN=ADCYAP1R1 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A4W6F684|A0A4W6F684_LATCA,51.675,418,185,6,31,435,27,440,2.65e-148,436,A0A4W6F684,Pituitary adenylate cyclase-activating polypeptide type I receptor-like OS=Lates calcarifer OX=8187 GN=LOC108879580 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A341C8D8|A0A341C8D8_NEOAA,52.644,416,187,5,21,429,21,433,2.72e-148,436,A0A341C8D8,pituitary adenylate cyclase-activating polypeptide type I receptor isoform X4 OS=Neophocaena asiaeorientalis asiaeorientalis OX=1706337 GN=ADCYAP1R1 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|I3KTR2|I3KTR2_ORENI,51.790,419,188,5,31,438,44,459,2.75e-148,437,I3KTR2,Adenylate cyclase activating polypeptide 1a (pituitary) receptor type I OS=Oreochromis niloticus OX=8128 PE=4 SV=2
sp|P41587|VIPR2_HUMAN,tr|A0A6J3IJP9|A0A6J3IJP9_SAPAP,52.506,419,181,6,22,429,64,475,2.77e-148,438,A0A6J3IJP9,pituitary adenylate cyclase-activating polypeptide type I receptor isoform X11 OS=Sapajus apella OX=9515 GN=ADCYAP1R1 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|M3ZQZ2|M3ZQZ2_XIPMA,51.620,432,195,5,13,438,3,426,3.12e-148,436,M3ZQZ2,Uncharacterized protein OS=Xiphophorus maculatus OX=8083 PE=4 SV=2
sp|P41587|VIPR2_HUMAN,tr|A0A673UKD1|A0A673UKD1_SURSU,48.590,461,198,6,1,429,1,454,3.33e-148,437,A0A673UKD1,ADCYAP receptor type I OS=Suricata suricatta OX=37032 GN=ADCYAP1R1 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A669QNU2|A0A669QNU2_PHACC,53.415,410,182,5,16,420,18,423,3.34e-148,436,A0A669QNU2,Vasoactive intestinal peptide receptor 1 OS=Phasianus colchicus OX=9054 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A6J3CPF9|A0A6J3CPF9_AYTFU,49.781,456,187,6,9,429,9,457,3.56e-148,437,A0A6J3CPF9,pituitary adenylate cyclase-activating polypeptide type I receptor isoform X5 OS=Aythya fuligula OX=219594 GN=ADCYAP1R1 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A340Y3W8|A0A340Y3W8_LIPVE,52.885,416,186,5,21,429,21,433,3.65e-148,436,A0A340Y3W8,pituitary adenylate cyclase-activating polypeptide type I receptor isoform X4 OS=Lipotes vexillifer OX=118797 GN=ADCYAP1R1 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A670JRS4|A0A670JRS4_PODMU,53.753,413,178,8,14,420,19,424,3.81e-148,436,A0A670JRS4,Uncharacterized protein OS=Podarcis muralis OX=64176 GN=VIPR1 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A2Y9RJM1|A0A2Y9RJM1_TRIMA,52.404,416,188,5,21,429,22,434,3.94e-148,436,A0A2Y9RJM1,pituitary adenylate cyclase-activating polypeptide type I receptor isoform X4 OS=Trichechus manatus latirostris OX=127582 GN=LOC101347453 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A2I0MRD7|A0A2I0MRD7_COLLI,53.444,421,185,7,5,420,10,424,4.07e-148,436,A0A2I0MRD7,Vasoactive intestinal peptide receptor 1 OS=Columba livia OX=8932 GN=VIPR1 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A6P8QJJ5|A0A6P8QJJ5_GEOSA,48.222,450,205,6,1,429,1,443,4.24e-148,436,A0A6P8QJJ5,pituitary adenylate cyclase-activating polypeptide type I receptor isoform X2 OS=Geotrypetes seraphini OX=260995 GN=ADCYAP1R1 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A6P6ICD1|A0A6P6ICD1_PUMCO,48.807,461,197,6,1,429,1,454,4.28e-148,437,A0A6P6ICD1,pituitary adenylate cyclase-activating polypeptide type I receptor isoform X4 OS=Puma concolor OX=9696 GN=ADCYAP1R1 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A6I9ZIC6|A0A6I9ZIC6_ACIJB,48.807,461,197,6,1,429,1,454,4.28e-148,437,A0A6I9ZIC6,pituitary adenylate cyclase-activating polypeptide type I receptor isoform X6 OS=Acinonyx jubatus OX=32536 GN=ADCYAP1R1 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A485NA59|A0A485NA59_LYNPA,48.807,461,197,6,1,429,1,454,4.28e-148,437,A0A485NA59,Alternatively spliced product of pacap receptor OS=Lynx pardinus OX=191816 GN=LYPA_23C000917 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A2I2UK30|A0A2I2UK30_FELCA,48.807,461,197,6,1,429,1,454,4.28e-148,437,A0A2I2UK30,ADCYAP receptor type I OS=Felis catus OX=9685 GN=ADCYAP1R1 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A4W6F8Q3|A0A4W6F8Q3_LATCA,51.675,418,185,6,31,435,28,441,4.57e-148,436,A0A4W6F8Q3,Pituitary adenylate cyclase-activating polypeptide type I receptor-like OS=Lates calcarifer OX=8187 GN=LOC108879580 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A5YMQ0|A5YMQ0_CHICK,49.781,456,187,6,9,429,9,457,4.68e-148,437,A5YMQ0,Pituitary adenylate cyclase-activating polypeptide type I receptor short form OS=Gallus gallus OX=9031 GN=PAC1 PE=2 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A668TZL1|A0A668TZL1_OREAU,51.923,416,186,5,31,435,44,456,6.22e-148,436,A0A668TZL1,Adenylate cyclase activating polypeptide 1a (pituitary) receptor type I OS=Oreochromis aureus OX=47969 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A2K6QPC5|A0A2K6QPC5_RHIRO,50.805,435,182,6,20,429,12,439,6.75e-148,436,A0A2K6QPC5,Uncharacterized protein OS=Rhinopithecus roxellana OX=61622 GN=ADCYAP1R1 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|K7GA46|K7GA46_PELSI,49.672,457,186,6,10,429,10,459,6.93e-148,436,K7GA46,Uncharacterized protein OS=Pelodiscus sinensis OX=13735 GN=ADCYAP1R1 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|U3JE10|U3JE10_FICAL,54.501,411,175,7,16,420,16,420,7.14e-148,435,U3JE10,Vasoactive intestinal peptide receptor 1 OS=Ficedula albicollis OX=59894 GN=VIPR1 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A665WR63|A0A665WR63_ECHNA,52.304,434,201,3,8,438,10,440,7.43e-148,435,A0A665WR63,Vasoactive intestinal polypeptide receptor 2-like OS=Echeneis naucrates OX=173247 GN=LOC115061268 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A4W6F9M1|A0A4W6F9M1_LATCA,51.675,418,185,6,31,435,29,442,8.15e-148,435,A0A4W6F9M1,Pituitary adenylate cyclase-activating polypeptide type I receptor-like OS=Lates calcarifer OX=8187 GN=LOC108879580 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A5F9CRP3|A0A5F9CRP3_RABIT,51.039,433,188,5,21,432,21,450,8.93e-148,436,A0A5F9CRP3,ADCYAP receptor type I OS=Oryctolagus cuniculus OX=9986 GN=ADCYAP1R1 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A671XBC5|A0A671XBC5_SPAAU,51.659,422,184,6,31,435,28,446,9.12e-148,435,A0A671XBC5,Pituitary adenylate cyclase-activating polypeptide type I receptor-like OS=Sparus aurata OX=8175 GN=LOC115591282 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A2K5EIW9|A0A2K5EIW9_AOTNA,49.669,453,188,7,10,429,9,454,9.17e-148,436,A0A2K5EIW9,ADCYAP receptor type I OS=Aotus nancymaae OX=37293 GN=ADCYAP1R1 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A6P7KF52|A0A6P7KF52_9TELE,53.364,431,188,6,18,438,20,447,9.41e-148,435,A0A6P7KF52,vasoactive intestinal polypeptide receptor 2-like OS=Parambassis ranga OX=210632 GN=LOC114452942 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A3B5QMZ1|A0A3B5QMZ1_XIPMA,51.740,431,194,5,14,438,16,438,9.42e-148,435,A0A3B5QMZ1,Uncharacterized protein OS=Xiphophorus maculatus OX=8083 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A5E4AHP8|A0A5E4AHP8_MARMO,51.537,423,195,5,20,435,20,439,9.51e-148,435,A0A5E4AHP8,Uncharacterized protein OS=Marmota monax OX=9995 GN=MONAX_5E018682 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|K7GGM6|K7GGM6_PELSI,53.412,425,183,7,19,436,4,420,1.16e-147,434,K7GGM6,Vasoactive intestinal peptide receptor 1 OS=Pelodiscus sinensis OX=13735 GN=VIPR1 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|W5MTH3|W5MTH3_LEPOC,54.342,403,174,5,34,429,39,438,1.26e-147,435,W5MTH3,ADCYAP receptor type I OS=Lepisosteus oculatus OX=7918 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|H2MCM8|H2MCM8_ORYLA,51.923,416,186,5,31,435,31,443,1.26e-147,435,H2MCM8,Uncharacterized protein OS=Oryzias latipes OX=8090 GN=LOC101163161 PE=4 SV=2
sp|P41587|VIPR2_HUMAN,tr|A0A1S3A8H9|A0A1S3A8H9_ERIEU,52.278,417,189,5,20,429,20,433,1.35e-147,435,A0A1S3A8H9,pituitary adenylate cyclase-activating polypeptide type I receptor isoform X4 OS=Erinaceus europaeus OX=9365 GN=ADCYAP1R1 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A4W6F689|A0A4W6F689_LATCA,51.675,418,185,6,31,435,86,499,1.45e-147,437,A0A4W6F689,Pituitary adenylate cyclase-activating polypeptide type I receptor-like OS=Lates calcarifer OX=8187 GN=LOC108879580 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A287BN91|A0A287BN91_PIG,50.805,435,184,5,22,429,22,453,1.58e-147,435,A0A287BN91,ADCYAP receptor type I OS=Sus scrofa OX=9823 GN=ADCYAP1R1 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A7N5P325|A0A7N5P325_AILME,49.130,460,198,6,1,429,1,455,1.60e-147,436,A0A7N5P325,ADCYAP receptor type I OS=Ailuropoda melanoleuca OX=9646 GN=ADCYAP1R1 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A2Y9T8Y5|A0A2Y9T8Y5_PHYMC,50.340,441,180,6,21,429,21,454,1.71e-147,435,A0A2Y9T8Y5,pituitary adenylate cyclase-activating polypeptide type I receptor isoform X5 OS=Physeter macrocephalus OX=9755 GN=ADCYAP1R1 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|H2MXR5|H2MXR5_ORYLA,53.207,421,185,7,23,438,26,439,1.74e-147,434,H2MXR5,Uncharacterized protein OS=Oryzias latipes OX=8090 GN=LOC101170814 PE=3 SV=2
sp|P41587|VIPR2_HUMAN,tr|A0A4W6F694|A0A4W6F694_LATCA,51.429,420,185,7,31,435,20,435,1.81e-147,434,A0A4W6F694,Pituitary adenylate cyclase-activating polypeptide type I receptor-like OS=Lates calcarifer OX=8187 GN=LOC108879580 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A3Q1D946|A0A3Q1D946_AMPOC,51.636,428,193,7,9,429,27,447,1.84e-147,435,A0A3Q1D946,Pituitary adenylate cyclase-activating polypeptide type I receptor-like OS=Amphiprion ocellaris OX=80972 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|I3JMT2|I3JMT2_ORENI,52.860,437,198,5,5,436,7,440,2.07e-147,434,I3JMT2,Uncharacterized protein OS=Oreochromis niloticus OX=8128 GN=LOC100707237 PE=3 SV=2
sp|P41587|VIPR2_HUMAN,tr|A0A452GTM1|A0A452GTM1_9SAUR,54.801,427,173,10,6,420,3,421,2.13e-147,434,A0A452GTM1,Vasoactive intestinal peptide receptor 1 OS=Gopherus agassizii OX=38772 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|Q6NXJ9|Q6NXJ9_MOUSE,49.775,444,192,5,20,435,20,460,2.14e-147,435,Q6NXJ9,Adenylate cyclase activating polypeptide 1 receptor 1 OS=Mus musculus OX=10090 GN=Adcyap1r1 PE=1 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A2K6DXY5|A0A2K6DXY5_MACNE,48.807,461,197,6,1,429,1,454,2.29e-147,435,A0A2K6DXY5,ADCYAP receptor type I OS=Macaca nemestrina OX=9545 GN=ADCYAP1R1 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A3P9NUU3|A0A3P9NUU3_POERE,51.202,416,189,5,31,435,31,443,2.51e-147,434,A0A3P9NUU3,ADCYAP receptor type I OS=Poecilia reticulata OX=8081 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A2K6FNH4|A0A2K6FNH4_PROCO,52.038,417,190,5,20,429,20,433,2.51e-147,434,A0A2K6FNH4,ADCYAP receptor type I OS=Propithecus coquereli OX=379532 GN=ADCYAP1R1 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A6G1QMC2|A0A6G1QMC2_9TELE,52.927,427,194,4,18,438,17,442,2.58e-147,434,A0A6G1QMC2,Vasoactive intestinal polypeptide receptor 2 OS=Channa argus OX=215402 GN=EXN66_Car019548 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A6J3CQM4|A0A6J3CQM4_AYTFU,53.563,407,180,6,18,420,10,411,2.73e-147,434,A0A6J3CQM4,vasoactive intestinal polypeptide receptor 1 OS=Aythya fuligula OX=219594 GN=VIPR1 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A671Q315|A0A671Q315_9TELE,62.254,355,125,6,87,438,10,358,2.85e-147,431,A0A671Q315,Vasoactive intestinal polypeptide receptor 2-like OS=Sinocyclocheilus anshuiensis OX=1608454 GN=LOC107656837 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|G1MT88|G1MT88_MELGA,50.112,447,181,6,9,420,9,448,3.39e-147,434,G1MT88,ADCYAP receptor type I OS=Meleagris gallopavo OX=9103 GN=ADCYAP1R1 PE=4 SV=2
sp|P41587|VIPR2_HUMAN,tr|A0A2U3WWS1|A0A2U3WWS1_ODORO,49.348,460,197,6,1,429,1,455,3.50e-147,434,A0A2U3WWS1,pituitary adenylate cyclase-activating polypeptide type I receptor isoform X4 OS=Odobenus rosmarus divergens OX=9708 GN=ADCYAP1R1 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A2K6SQH5|A0A2K6SQH5_SAIBB,49.887,443,183,6,19,429,19,454,3.54e-147,434,A0A2K6SQH5,ADCYAP receptor type I OS=Saimiri boliviensis boliviensis OX=39432 GN=ADCYAP1R1 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A3Q1EUU6|A0A3Q1EUU6_9TELE,51.147,436,195,8,1,429,1,425,3.66e-147,434,A0A3Q1EUU6,Pituitary adenylate cyclase-activating polypeptide type I receptor-like OS=Acanthochromis polyacanthus OX=80966 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|M3ZVZ5|M3ZVZ5_XIPMA,50.962,416,190,5,31,435,31,443,3.96e-147,434,M3ZVZ5,Uncharacterized protein OS=Xiphophorus maculatus OX=8083 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|F7DV72|F7DV72_ORNAN,49.666,449,191,8,5,429,2,439,3.99e-147,434,F7DV72,ADCYAP receptor type I OS=Ornithorhynchus anatinus OX=9258 GN=ADCYAP1R1 PE=4 SV=3
sp|P41587|VIPR2_HUMAN,tr|A0A2I3LYH2|A0A2I3LYH2_PAPAN,48.913,460,197,7,1,429,1,453,4.07e-147,434,A0A2I3LYH2,ADCYAP receptor type I OS=Papio anubis OX=9555 GN=ADCYAP1R1 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A3Q3FQM8|A0A3Q3FQM8_9LABR,50.957,418,189,5,31,435,27,441,4.50e-147,433,A0A3Q3FQM8,Pituitary adenylate cyclase-activating polypeptide type I receptor-like OS=Labrus bergylta OX=56723 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A2Y9H1B4|A0A2Y9H1B4_NEOSC,48.913,460,199,6,1,429,1,455,4.65e-147,434,A0A2Y9H1B4,pituitary adenylate cyclase-activating polypeptide type I receptor isoform X4 OS=Neomonachus schauinslandi OX=29088 GN=ADCYAP1R1 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|G3PYK6|G3PYK6_GASAC,51.748,429,192,8,9,429,5,426,5.72e-147,433,G3PYK6,Adenylate cyclase activating polypeptide 1a (pituitary) receptor type I OS=Gasterosteus aculeatus OX=69293 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A452IRS3|A0A452IRS3_9SAUR,48.918,462,200,5,1,429,1,459,5.99e-147,434,A0A452IRS3,ADCYAP receptor type I OS=Gopherus agassizii OX=38772 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|E5F1H6|E5F1H6_PIG,50.688,436,184,5,22,429,22,454,6.10e-147,434,E5F1H6,ADCYAP receptor type I OS=Sus scrofa OX=9823 GN=ADCYAP1R1 PE=2 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A2K6M072|A0A2K6M072_RHIBE,50.455,440,179,6,22,429,22,454,6.23e-147,434,A0A2K6M072,Uncharacterized protein OS=Rhinopithecus bieti OX=61621 GN=ADCYAP1R1 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A5F5PED3|A0A5F5PED3_HORSE,52.068,411,182,5,31,429,27,434,6.27e-147,433,A0A5F5PED3,ADCYAP receptor type I OS=Equus caballus OX=9796 GN=ADCYAP1R1 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A4W5QHE5|A0A4W5QHE5_9TELE,55.208,384,164,4,51,429,26,406,7.55e-147,432,A0A4W5QHE5,Adenylate cyclase activating polypeptide 1a (pituitary) receptor type I OS=Hucho hucho OX=62062 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A5F4BXL6|A0A5F4BXL6_CANLF,49.020,459,201,5,1,429,1,456,8.10e-147,434,A0A5F4BXL6,ADCYAP receptor type I OS=Canis lupus familiaris OX=9615 GN=ADCYAP1R1 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A3Q7UNU2|A0A3Q7UNU2_VULVU,49.020,459,201,5,1,429,1,456,8.94e-147,434,A0A3Q7UNU2,pituitary adenylate cyclase-activating polypeptide type I receptor isoform X3 OS=Vulpes vulpes OX=9627 GN=ADCYAP1R1 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A663M8F6|A0A663M8F6_ATHCN,50.225,444,186,5,18,429,23,463,8.97e-147,434,A0A663M8F6,ADCYAP receptor type I OS=Athene cunicularia OX=194338 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|F1P200|F1P200_CHICK,53.528,411,179,7,16,420,18,422,9.67e-147,432,F1P200,Uncharacterized protein OS=Gallus gallus OX=9031 GN=VIPR1 PE=3 SV=2
sp|P41587|VIPR2_HUMAN,tr|A0A3M0JUG8|A0A3M0JUG8_HIRRU,54.412,408,176,6,18,420,101,503,9.85e-147,436,A0A3M0JUG8,Uncharacterized protein OS=Hirundo rustica rustica OX=333673 GN=DUI87_17842 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A2Y9JDB5|A0A2Y9JDB5_ENHLU,49.130,460,198,6,1,429,1,455,1.02e-146,433,A0A2Y9JDB5,pituitary adenylate cyclase-activating polypeptide type I receptor isoform X3 OS=Enhydra lutris kenyoni OX=391180 GN=LOC111147323 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A4X2LNU5|A0A4X2LNU5_VOMUR,52.078,409,183,4,31,429,17,422,1.07e-146,432,A0A4X2LNU5,ADCYAP receptor type I OS=Vombatus ursinus OX=29139 GN=ADCYAP1R1 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A671XBP4|A0A671XBP4_SPAAU,54.103,390,169,4,52,435,42,427,1.14e-146,432,A0A671XBP4,Pituitary adenylate cyclase-activating polypeptide type I receptor-like OS=Sparus aurata OX=8175 GN=LOC115591282 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A674IUT9|A0A674IUT9_TERCA,50.922,434,188,5,18,429,21,451,1.20e-146,433,A0A674IUT9,ADCYAP receptor type I OS=Terrapene carolina triunguis OX=2587831 GN=ADCYAP1R1 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|H3DMQ7|H3DMQ7_TETNG,50.816,429,196,7,9,429,5,426,1.43e-146,432,H3DMQ7,Adenylate cyclase activating polypeptide 1a (pituitary) receptor type I OS=Tetraodon nigroviridis OX=99883 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A3Q7P5X0|A0A3Q7P5X0_CALUR,49.130,460,198,6,1,429,1,455,1.46e-146,433,A0A3Q7P5X0,pituitary adenylate cyclase-activating polypeptide type I receptor isoform X4 OS=Callorhinus ursinus OX=34884 GN=ADCYAP1R1 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|F6Y311|F6Y311_CALJA,50.227,440,180,6,22,429,22,454,1.57e-146,433,F6Y311,ADCYAP receptor type I OS=Callithrix jacchus OX=9483 GN=ADCYAP1R1 PE=2 SV=2
sp|P41587|VIPR2_HUMAN,tr|A0A2K5Q978|A0A2K5Q978_CEBIM,50.227,440,180,6,22,429,22,454,1.70e-146,433,A0A2K5Q978,ADCYAP receptor type I OS=Cebus imitator OX=2715852 GN=ADCYAP1R1 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A1U7T9I8|A0A1U7T9I8_CARSF,50.113,441,181,6,21,429,21,454,1.77e-146,433,A0A1U7T9I8,pituitary adenylate cyclase-activating polypeptide type I receptor isoform X1 OS=Carlito syrichta OX=1868482 GN=ADCYAP1R1 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A2U9C1J3|A0A2U9C1J3_SCOMX,51.843,407,185,4,31,429,137,540,1.83e-146,436,A0A2U9C1J3,Pituitary adenylate cyclase-activating polypeptide 1B OS=Scophthalmus maximus OX=52904 GN=SMAX5B_009241 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A2U9C1J3|A0A2U9C1J3_SCOMX,43.103,58,30,1,31,85,30,87,9.69e-07,60.5,A0A2U9C1J3,Pituitary adenylate cyclase-activating polypeptide 1B OS=Scophthalmus maximus OX=52904 GN=SMAX5B_009241 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A3P8UB80|A0A3P8UB80_AMPPE,52.567,409,183,6,28,429,16,420,1.97e-146,431,A0A3P8UB80,Adenylate cyclase activating polypeptide 1a (pituitary) receptor type I OS=Amphiprion percula OX=161767 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A2K5XNW8|A0A2K5XNW8_MANLE,48.478,460,199,6,1,429,1,453,2.02e-146,432,A0A2K5XNW8,ADCYAP receptor type I OS=Mandrillus leucophaeus OX=9568 GN=ADCYAP1R1 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A3Q2D0N8|A0A3Q2D0N8_CYPVA,51.826,438,206,4,5,438,7,443,2.07e-146,432,A0A3Q2D0N8,Vasoactive intestinal polypeptide receptor 2-like OS=Cyprinodon variegatus OX=28743 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|H3BXU4|H3BXU4_TETNG,51.707,410,180,6,31,429,31,433,2.10e-146,432,H3BXU4,Adenylate cyclase activating polypeptide 1a (pituitary) receptor type I OS=Tetraodon nigroviridis OX=99883 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,sp|P41586|PACR_HUMAN,50.227,440,180,6,22,429,22,454,2.13e-146,432,P41586,Pituitary adenylate cyclase-activating polypeptide type I receptor OS=Homo sapiens OX=9606 GN=ADCYAP1R1 PE=1 SV=1
sp|P41587|VIPR2_HUMAN,tr|H2QUD9|H2QUD9_PANTR,50.227,440,180,6,22,429,22,454,2.13e-146,432,H2QUD9,ADCYAP receptor type I OS=Pan troglodytes OX=9598 GN=ADCYAP1R1 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|H3BY43|H3BY43_TETNG,51.961,408,180,6,31,429,27,427,2.18e-146,431,H3BY43,Adenylate cyclase activating polypeptide 1a (pituitary) receptor type I OS=Tetraodon nigroviridis OX=99883 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A2I2ZHJ5|A0A2I2ZHJ5_GORGO,50.227,440,180,6,22,429,22,454,2.28e-146,432,A0A2I2ZHJ5,ADCYAP receptor type I OS=Gorilla gorilla gorilla OX=9595 GN=ADCYAP1R1 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A2K5M353|A0A2K5M353_CERAT,48.478,460,199,6,1,429,1,453,2.48e-146,432,A0A2K5M353,ADCYAP receptor type I OS=Cercocebus atys OX=9531 GN=ADCYAP1R1 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A671XHY2|A0A671XHY2_SPAAU,53.708,391,168,4,55,435,31,418,2.65e-146,431,A0A671XHY2,Pituitary adenylate cyclase-activating polypeptide type I receptor-like OS=Sparus aurata OX=8175 GN=LOC115591282 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A3P8UT76|A0A3P8UT76_CYNSE,50.957,418,189,5,31,435,33,447,2.79e-146,431,A0A3P8UT76,Pituitary adenylate cyclase-activating polypeptide type I receptor-like OS=Cynoglossus semilaevis OX=244447 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A4W2EGL5|A0A4W2EGL5_BOBOX,49.548,442,184,6,20,429,20,454,2.83e-146,432,A0A4W2EGL5,Uncharacterized protein OS=Bos indicus x Bos taurus OX=30522 GN=ADCYAP1R1 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A2K6QPC2|A0A2K6QPC2_RHIRO,50.227,440,180,6,22,429,22,454,2.96e-146,432,A0A2K6QPC2,Uncharacterized protein OS=Rhinopithecus roxellana OX=61622 GN=ADCYAP1R1 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A6J0AGM3|A0A6J0AGM3_VICPA,50.343,437,186,5,21,429,21,454,3.16e-146,432,A0A6J0AGM3,pituitary adenylate cyclase-activating polypeptide type I receptor isoform X3 OS=Vicugna pacos OX=30538 GN=ADCYAP1R1 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|I3KTR1|I3KTR1_ORENI,53.401,397,172,4,52,438,3,396,3.28e-146,429,I3KTR1,Adenylate cyclase activating polypeptide 1a (pituitary) receptor type I OS=Oreochromis niloticus OX=8128 PE=4 SV=2
sp|P41587|VIPR2_HUMAN,tr|A0A663M959|A0A663M959_ATHCN,50.228,438,189,5,18,429,26,460,3.49e-146,432,A0A663M959,ADCYAP receptor type I OS=Athene cunicularia OX=194338 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A4U5UVX5|A0A4U5UVX5_COLLU,65.831,319,106,2,120,438,33,348,3.59e-146,427,A0A4U5UVX5,Vasoactive intestinal polypeptide receptor 2 OS=Collichthys lucidus OX=240159 GN=D9C73_014407 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A672G6L1|A0A672G6L1_SALFA,52.323,409,184,6,28,429,22,426,3.79e-146,431,A0A672G6L1,Adenylate cyclase activating polypeptide 1a (pituitary) receptor type I OS=Salarias fasciatus OX=181472 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A672G6M9|A0A672G6M9_SALFA,55.795,371,154,5,28,392,29,395,3.96e-146,431,A0A672G6M9,Adenylate cyclase activating polypeptide 1a (pituitary) receptor type I OS=Salarias fasciatus OX=181472 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|H3CL60|H3CL60_TETNG,51.707,410,180,6,31,429,28,430,4.20e-146,431,H3CL60,Adenylate cyclase activating polypeptide 1a (pituitary) receptor type I OS=Tetraodon nigroviridis OX=99883 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A665WC51|A0A665WC51_ECHNA,52.911,395,173,4,51,435,39,430,4.34e-146,431,A0A665WC51,Adenylate cyclase activating polypeptide 1a (pituitary) receptor type I OS=Echeneis naucrates OX=173247 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A671XET5|A0A671XET5_SPAAU,53.418,395,167,4,55,435,36,427,4.37e-146,430,A0A671XET5,Pituitary adenylate cyclase-activating polypeptide type I receptor-like OS=Sparus aurata OX=8175 GN=LOC115591282 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A4D9E9G0|A0A4D9E9G0_9SAUR,48.918,462,200,5,1,429,1,459,4.63e-146,432,A0A4D9E9G0,Neuropeptide Y receptor type 4-like OS=Platysternon megacephalum OX=55544 GN=DR999_PMT13061 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A672GAD7|A0A672GAD7_SALFA,50.926,432,193,7,13,429,16,443,4.86e-146,431,A0A672GAD7,Adenylate cyclase activating polypeptide 1a (pituitary) receptor type I OS=Salarias fasciatus OX=181472 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A7N4NZR0|A0A7N4NZR0_SARHA,50.463,432,184,6,21,429,1,425,5.08e-146,431,A0A7N4NZR0,ADCYAP receptor type I OS=Sarcophilus harrisii OX=9305 GN=ADCYAP1R1 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A6P7MEK1|A0A6P7MEK1_BETSP,54.265,422,181,6,23,438,25,440,5.15e-146,431,A0A6P7MEK1,vasoactive intestinal polypeptide receptor 2-like isoform X2 OS=Betta splendens OX=158456 GN=LOC114854499 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A4V6AQA5|A0A4V6AQA5_COLLU,51.515,429,194,6,9,429,5,427,5.29e-146,431,A0A4V6AQA5,Pituitary adenylate cyclase-activating polypeptide type I receptor OS=Collichthys lucidus OX=240159 GN=D9C73_014118 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A3P8UHC1|A0A3P8UHC1_AMPPE,52.567,409,183,6,28,429,33,437,5.33e-146,431,A0A3P8UHC1,Adenylate cyclase activating polypeptide 1a (pituitary) receptor type I OS=Amphiprion percula OX=161767 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|G3PYK8|G3PYK8_GASAC,52.683,410,182,7,28,429,29,434,5.50e-146,431,G3PYK8,Adenylate cyclase activating polypeptide 1a (pituitary) receptor type I OS=Gasterosteus aculeatus OX=69293 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A669F251|A0A669F251_ORENI,53.401,397,172,4,52,438,19,412,5.73e-146,429,A0A669F251,Adenylate cyclase activating polypeptide 1a (pituitary) receptor type I OS=Oreochromis niloticus OX=8128 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|W5MTG6|W5MTG6_LEPOC,49.891,457,186,8,9,429,9,458,5.76e-146,432,W5MTG6,ADCYAP receptor type I OS=Lepisosteus oculatus OX=7918 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A7N6A4Q9|A0A7N6A4Q9_ANATE,53.563,435,189,6,14,437,10,442,5.95e-146,431,A0A7N6A4Q9,Vasoactive intestinal polypeptide receptor 2-like OS=Anabas testudineus OX=64144 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A4W6F9V9|A0A4W6F9V9_LATCA,53.418,395,170,5,51,435,34,424,6.52e-146,430,A0A4W6F9V9,Pituitary adenylate cyclase-activating polypeptide type I receptor-like OS=Lates calcarifer OX=8187 GN=LOC108879580 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|R0LAV0|R0LAV0_ANAPL,48.908,458,181,6,18,429,2,452,7.37e-146,431,R0LAV0,Pituitary adenylate cyclase-activating polypeptide type I receptor (Fragment) OS=Anas platyrhynchos OX=8839 GN=Anapl_11848 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A3P8ZA21|A0A3P8ZA21_ESOLU,51.905,420,184,6,31,435,30,446,8.76e-146,430,A0A3P8ZA21,Pituitary adenylate cyclase-activating polypeptide type I receptor OS=Esox lucius OX=8010 PE=4 SV=2
sp|P41587|VIPR2_HUMAN,tr|A0A668U3H8|A0A668U3H8_OREAU,53.553,394,170,4,52,435,12,402,8.86e-146,429,A0A668U3H8,Adenylate cyclase activating polypeptide 1a (pituitary) receptor type I OS=Oreochromis aureus OX=47969 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A6Q2Y853|A0A6Q2Y853_ESOLU,51.905,420,184,6,31,435,25,441,8.91e-146,430,A0A6Q2Y853,Pituitary adenylate cyclase-activating polypeptide type I receptor OS=Esox lucius OX=8010 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A7N4NWU8|A0A7N4NWU8_SARHA,50.346,433,185,6,20,429,17,442,9.93e-146,430,A0A7N4NWU8,ADCYAP receptor type I OS=Sarcophilus harrisii OX=9305 GN=ADCYAP1R1 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A668U289|A0A668U289_OREAU,53.553,394,170,4,52,435,3,393,1.01e-145,428,A0A668U289,Adenylate cyclase activating polypeptide 1a (pituitary) receptor type I OS=Oreochromis aureus OX=47969 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A6Q2WST5|A0A6Q2WST5_ESOLU,51.905,420,184,6,31,435,35,451,1.15e-145,430,A0A6Q2WST5,Pituitary adenylate cyclase-activating polypeptide type I receptor OS=Esox lucius OX=8010 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A3Q3WZW4|A0A3Q3WZW4_MOLML,52.555,411,185,7,25,429,26,432,1.23e-145,430,A0A3Q3WZW4,Adenylate cyclase activating polypeptide 1a (pituitary) receptor type I OS=Mola mola OX=94237 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A6P5BK74|A0A6P5BK74_BOSIN,49.548,442,184,6,20,429,37,471,1.28e-145,431,A0A6P5BK74,pituitary adenylate cyclase-activating polypeptide type I receptor isoform X3 OS=Bos indicus OX=9915 GN=ADCYAP1R1 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A668TZU7|A0A668TZU7_OREAU,53.553,394,170,4,52,435,20,410,1.29e-145,429,A0A668TZU7,Adenylate cyclase activating polypeptide 1a (pituitary) receptor type I OS=Oreochromis aureus OX=47969 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A670IUN2|A0A670IUN2_PODMU,48.578,457,184,9,14,429,27,473,1.30e-145,431,A0A670IUN2,Uncharacterized protein OS=Podarcis muralis OX=64176 GN=ADCYAP1R1 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A668U3R0|A0A668U3R0_OREAU,53.553,394,170,4,52,435,30,420,1.35e-145,429,A0A668U3R0,Adenylate cyclase activating polypeptide 1a (pituitary) receptor type I OS=Oreochromis aureus OX=47969 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A668TZS2|A0A668TZS2_OREAU,53.553,394,170,4,52,435,19,409,1.38e-145,428,A0A668TZS2,Adenylate cyclase activating polypeptide 1a (pituitary) receptor type I OS=Oreochromis aureus OX=47969 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A6P3GCV3|A0A6P3GCV3_BISBI,49.548,442,184,6,20,429,37,471,1.44e-145,431,A0A6P3GCV3,pituitary adenylate cyclase-activating polypeptide type I receptor isoform X3 OS=Bison bison bison OX=43346 GN=ADCYAP1R1 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A669ELC4|A0A669ELC4_ORENI,53.133,399,172,4,52,438,20,415,1.67e-145,428,A0A669ELC4,Adenylate cyclase activating polypeptide 1a (pituitary) receptor type I OS=Oreochromis niloticus OX=8128 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A2I4BSL5|A0A2I4BSL5_9TELE,53.089,437,198,6,7,438,89,523,1.74e-145,432,A0A2I4BSL5,vasoactive intestinal polypeptide receptor 2-like OS=Austrofundulus limnaeus OX=52670 GN=LOC106522314 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A6J3IL25|A0A6J3IL25_SAPAP,50.227,440,180,6,22,429,64,496,1.78e-145,432,A0A6J3IL25,pituitary adenylate cyclase-activating polypeptide type I receptor isoform X10 OS=Sapajus apella OX=9515 GN=ADCYAP1R1 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A3Q3X982|A0A3Q3X982_MOLML,50.000,426,189,6,31,435,7,429,1.81e-145,429,A0A3Q3X982,Adenylate cyclase activating polypeptide 1a (pituitary) receptor type I OS=Mola mola OX=94237 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A6Q2XNM9|A0A6Q2XNM9_ESOLU,51.905,420,184,6,31,435,32,448,1.88e-145,429,A0A6Q2XNM9,Pituitary adenylate cyclase-activating polypeptide type I receptor OS=Esox lucius OX=8010 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A2Y9E2W0|A0A2Y9E2W0_TRIMA,50.114,437,187,5,21,429,22,455,1.95e-145,430,A0A2Y9E2W0,pituitary adenylate cyclase-activating polypeptide type I receptor isoform X3 OS=Trichechus manatus latirostris OX=127582 GN=LOC101347453 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A4W4FFS3|A0A4W4FFS3_ELEEL,50.234,428,192,8,21,435,15,434,2.23e-145,429,A0A4W4FFS3,Uncharacterized protein OS=Electrophorus electricus OX=8005 GN=LOC113586160 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A340XXW2|A0A340XXW2_LIPVE,50.572,437,185,5,21,429,21,454,2.24e-145,430,A0A340XXW2,pituitary adenylate cyclase-activating polypeptide type I receptor isoform X5 OS=Lipotes vexillifer OX=118797 GN=ADCYAP1R1 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A493T3C6|A0A493T3C6_ANAPP,48.511,470,186,7,9,429,9,471,2.31e-145,431,A0A493T3C6,ADCYAP receptor type I OS=Anas platyrhynchos platyrhynchos OX=8840 GN=ADCYAP1R1 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A2Y9NXG8|A0A2Y9NXG8_DELLE,51.422,422,176,4,34,429,36,454,2.44e-145,430,A0A2Y9NXG8,pituitary adenylate cyclase-activating polypeptide type I receptor isoform X4 OS=Delphinapterus leucas OX=9749 GN=ADCYAP1R1 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A3Q3MFW5|A0A3Q3MFW5_9TELE,52.913,412,179,7,28,429,28,434,2.52e-145,429,A0A3Q3MFW5,Pituitary adenylate cyclase-activating polypeptide type I receptor-like OS=Mastacembelus armatus OX=205130 PE=4 SV=2
sp|P41587|VIPR2_HUMAN,tr|A0A341C7L7|A0A341C7L7_NEOAA,50.343,437,186,5,21,429,21,454,2.58e-145,430,A0A341C7L7,pituitary adenylate cyclase-activating polypeptide type I receptor isoform X5 OS=Neophocaena asiaeorientalis asiaeorientalis OX=1706337 GN=ADCYAP1R1 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A2I4C050|A0A2I4C050_9TELE,51.442,416,188,5,31,435,29,441,2.80e-145,429,A0A2I4C050,pituitary adenylate cyclase-activating polypeptide type I receptor-like OS=Austrofundulus limnaeus OX=52670 GN=LOC106524204 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|H0WJM1|H0WJM1_OTOGA,49.011,455,190,8,10,429,9,456,2.82e-145,430,H0WJM1,ADCYAP receptor type I OS=Otolemur garnettii OX=30611 GN=ADCYAP1R1 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A3Q3WJP7|A0A3Q3WJP7_MOLML,52.439,410,183,7,28,429,8,413,3.04e-145,428,A0A3Q3WJP7,Adenylate cyclase activating polypeptide 1a (pituitary) receptor type I OS=Mola mola OX=94237 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A2K6FNE4|A0A2K6FNE4_PROCO,50.943,424,191,5,20,429,20,440,3.04e-145,429,A0A2K6FNE4,ADCYAP receptor type I OS=Propithecus coquereli OX=379532 GN=ADCYAP1R1 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A4W6BSG1|A0A4W6BSG1_LATCA,52.195,410,184,6,28,429,14,419,3.20e-145,428,A0A4W6BSG1,Adenylate cyclase activating polypeptide 1a (pituitary) receptor type I OS=Lates calcarifer OX=8187 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A6P8W456|A0A6P8W456_GYMAC,49.881,419,195,5,19,429,22,433,3.23e-145,429,A0A6P8W456,pituitary adenylate cyclase-activating polypeptide type I receptor isoform X2 OS=Gymnodraco acuticeps OX=8218 GN=adcyap1r1b PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A6J3RWT2|A0A6J3RWT2_TURTR,50.343,437,186,6,21,429,21,454,3.46e-145,429,A0A6J3RWT2,pituitary adenylate cyclase-activating polypeptide type I receptor isoform X2 OS=Tursiops truncatus OX=9739 GN=ADCYAP1R1 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A669R2E1|A0A669R2E1_PHACC,54.156,397,173,5,29,420,2,394,3.49e-145,427,A0A669R2E1,Vasoactive intestinal peptide receptor 1 OS=Phasianus colchicus OX=9054 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A1D5RG74|A0A1D5RG74_MACMU,50.000,448,183,7,14,429,58,496,3.99e-145,431,A0A1D5RG74,ADCYAP receptor type I OS=Macaca mulatta OX=9544 GN=ADCYAP1R1 PE=4 SV=2
sp|P41587|VIPR2_HUMAN,tr|A0A096LVA3|A0A096LVA3_POEFO,50.831,421,184,7,31,435,31,444,4.83e-145,428,A0A096LVA3,Pituitary adenylate cyclase-activating polypeptide type I receptor-like OS=Poecilia formosa OX=48698 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A674GXP8|A0A674GXP8_TAEGU,54.798,396,169,6,30,420,3,393,5.63e-145,427,A0A674GXP8,Uncharacterized protein OS=Taeniopygia guttata OX=59729 GN=VIPR1 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A4W6BL91|A0A4W6BL91_LATCA,52.195,410,184,6,28,429,24,429,5.63e-145,428,A0A4W6BL91,Adenylate cyclase activating polypeptide 1a (pituitary) receptor type I OS=Lates calcarifer OX=8187 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A3Q3WRP1|A0A3Q3WRP1_MOLML,52.439,410,183,7,28,429,25,430,5.69e-145,428,A0A3Q3WRP1,Adenylate cyclase activating polypeptide 1a (pituitary) receptor type I OS=Mola mola OX=94237 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A0P7V655|A0A0P7V655_SCLFO,53.506,385,171,4,49,429,13,393,5.80e-145,427,A0A0P7V655,Pituitary adenylate cyclase-activating polypeptide type I receptor-like OS=Scleropages formosus OX=113540 GN=Z043_110894 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A671XCD8|A0A671XCD8_SPAAU,52.369,401,168,4,55,435,18,415,5.95e-145,427,A0A671XCD8,Pituitary adenylate cyclase-activating polypeptide type I receptor-like OS=Sparus aurata OX=8175 GN=LOC115591282 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A2R9A3V2|A0A2R9A3V2_PANPA,52.195,410,167,4,46,429,4,410,6.47e-145,427,A0A2R9A3V2,ADCYAP receptor type I OS=Pan paniscus OX=9597 GN=ADCYAP1R1 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A3Q3FTP0|A0A3Q3FTP0_9LABR,54.369,412,175,7,31,438,1,403,6.79e-145,426,A0A3Q3FTP0,Vasoactive intestinal peptide receptor 2 OS=Labrus bergylta OX=56723 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A6P7KWN5|A0A6P7KWN5_BETSP,50.000,426,200,5,9,429,4,421,7.02e-145,427,A0A6P7KWN5,pituitary adenylate cyclase-activating polypeptide type I receptor-like isoform X6 OS=Betta splendens OX=158456 GN=LOC114843992 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A6P7MFR7|A0A6P7MFR7_BETSP,54.374,423,180,7,23,438,25,441,7.11e-145,427,A0A6P7MFR7,vasoactive intestinal polypeptide receptor 2-like isoform X1 OS=Betta splendens OX=158456 GN=LOC114854499 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A3Q1CHU5|A0A3Q1CHU5_AMPOC,52.941,391,174,4,51,435,20,406,7.23e-145,426,A0A3Q1CHU5,Pituitary adenylate cyclase-activating polypeptide type I receptor-like OS=Amphiprion ocellaris OX=80972 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A484D143|A0A484D143_PERFV,50.117,427,189,7,27,435,28,448,7.33e-145,428,A0A484D143,Uncharacterized protein OS=Perca flavescens OX=8167 GN=EPR50_G00102980 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A6J2WR48|A0A6J2WR48_CHACN,51.636,428,188,7,23,435,5,428,7.60e-145,427,A0A6J2WR48,pituitary adenylate cyclase-activating polypeptide type I receptor-like OS=Chanos chanos OX=29144 GN=LOC115827339 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A4W5QHD0|A0A4W5QHD0_9TELE,53.133,399,164,4,51,429,38,433,7.97e-145,428,A0A4W5QHD0,Adenylate cyclase activating polypeptide 1a (pituitary) receptor type I OS=Hucho hucho OX=62062 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A3P9CXV4|A0A3P9CXV4_9CICH,52.656,433,197,5,9,436,11,440,8.75e-145,427,A0A3P9CXV4,Vasoactive intestinal polypeptide receptor 2 OS=Maylandia zebra OX=106582 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A6Q2XHJ9|A0A6Q2XHJ9_ESOLU,50.577,433,199,5,15,435,14,443,1.03e-144,427,A0A6Q2XHJ9,Pituitary adenylate cyclase-activating polypeptide type I receptor OS=Esox lucius OX=8010 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A1S3A8K2|A0A1S3A8K2_ERIEU,49.772,438,189,5,20,429,20,454,1.07e-144,428,A0A1S3A8K2,pituitary adenylate cyclase-activating polypeptide type I receptor isoform X3 OS=Erinaceus europaeus OX=9365 GN=ADCYAP1R1 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|H2MTZ1|H2MTZ1_ORYLA,52.323,409,184,6,28,429,21,425,1.35e-144,427,H2MTZ1,Uncharacterized protein OS=Oryzias latipes OX=8090 GN=LOC101159384 PE=4 SV=2
sp|P41587|VIPR2_HUMAN,tr|A0A4W6F6B1|A0A4W6F6B1_LATCA,53.165,395,171,5,52,435,45,436,1.36e-144,427,A0A4W6F6B1,Pituitary adenylate cyclase-activating polypeptide type I receptor-like OS=Lates calcarifer OX=8187 GN=LOC108879580 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A218UHL7|A0A218UHL7_9PASE,53.218,404,157,4,55,429,1,401,1.37e-144,426,A0A218UHL7,Pituitary adenylate cyclase-activating polypeptide type I receptor OS=Lonchura striata domestica OX=299123 GN=ADCYAP1R1 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A5E4AF26|A0A5E4AF26_MARMO,54.145,386,169,4,55,435,1,383,1.49e-144,425,A0A5E4AF26,Uncharacterized protein OS=Marmota monax OX=9995 GN=MONAX_5E018682 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A3P8TZH2|A0A3P8TZH2_AMPPE,52.405,395,175,4,51,435,20,411,1.72e-144,426,A0A3P8TZH2,Adenylate cyclase activating polypeptide 1a (pituitary) receptor type I OS=Amphiprion percula OX=161767 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|Q5K4T7|Q5K4T7_SPAAU,51.039,433,189,8,9,429,5,426,1.74e-144,427,Q5K4T7,ADCYAP receptor type I OS=Sparus aurata OX=8175 GN=pacap1A PE=2 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A3Q4GDP3|A0A3Q4GDP3_NEOBR,53.066,424,191,5,18,436,9,429,1.86e-144,426,A0A3Q4GDP3,Vasoactive intestinal polypeptide receptor 2-like OS=Neolamprologus brichardi OX=32507 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A0P7WFY2|A0A0P7WFY2_SCLFO,54.822,394,164,6,51,435,11,399,2.19e-144,425,A0A0P7WFY2,Pituitary adenylate cyclase-activating polypeptide type I receptor-like OS=Scleropages formosus OX=113540 GN=Z043_119442 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A6J2PGC4|A0A6J2PGC4_COTGO,50.835,419,189,6,31,435,31,446,2.37e-144,427,A0A6J2PGC4,LOW QUALITY PROTEIN: pituitary adenylate cyclase-activating polypeptide type I receptor-like OS=Cottoperca gobio OX=56716 GN=LOC115006771 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|H3C5M9|H3C5M9_TETNG,51.463,410,187,6,28,429,39,444,2.42e-144,427,H3C5M9,Adenylate cyclase activating polypeptide 1a (pituitary) receptor type I OS=Tetraodon nigroviridis OX=99883 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A6J2MMM7|A0A6J2MMM7_9CHIR,49.771,436,184,5,26,429,18,450,2.45e-144,427,A0A6J2MMM7,pituitary adenylate cyclase-activating polypeptide type I receptor isoform X4 OS=Phyllostomus discolor OX=89673 GN=ADCYAP1R1 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A669E6E5|A0A669E6E5_ORENI,52.217,406,172,4,52,438,18,420,2.46e-144,426,A0A669E6E5,Adenylate cyclase activating polypeptide 1a (pituitary) receptor type I OS=Oreochromis niloticus OX=8128 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A1S3GNZ1|A0A1S3GNZ1_DIPOR,47.023,487,200,6,1,432,1,484,2.48e-144,428,A0A1S3GNZ1,pituitary adenylate cyclase-activating polypeptide type I receptor isoform X2 OS=Dipodomys ordii OX=10020 GN=Adcyap1r1 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A2U9BIP6|A0A2U9BIP6_SCOMX,51.220,410,188,6,28,429,33,438,2.75e-144,427,A0A2U9BIP6,Pituitary adenylate-cyclase activating polypeptide receptor 1A OS=Scophthalmus maximus OX=52904 GN=SMAX5B_006643 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A3B5R5K9|A0A3B5R5K9_XIPMA,51.589,409,186,6,28,429,21,424,2.93e-144,426,A0A3B5R5K9,Uncharacterized protein OS=Xiphophorus maculatus OX=8083 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A3P8UCV5|A0A3P8UCV5_AMPPE,54.286,385,167,5,50,429,32,412,3.16e-144,426,A0A3P8UCV5,Adenylate cyclase activating polypeptide 1a (pituitary) receptor type I OS=Amphiprion percula OX=161767 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|G1MT78|G1MT78_MELGA,52.696,408,151,6,18,390,19,419,3.26e-144,425,G1MT78,ADCYAP receptor type I OS=Meleagris gallopavo OX=9103 GN=ADCYAP1R1 PE=4 SV=2
sp|P41587|VIPR2_HUMAN,tr|A0A665WCK3|A0A665WCK3_ECHNA,52.911,395,167,5,51,435,30,415,3.36e-144,425,A0A665WCK3,Adenylate cyclase activating polypeptide 1a (pituitary) receptor type I OS=Echeneis naucrates OX=173247 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A3P9B674|A0A3P9B674_9CICH,57.033,391,143,7,51,438,16,384,3.45e-144,424,A0A3P9B674,Vasoactive intestinal peptide receptor 2 OS=Maylandia zebra OX=106582 GN=VIPR2 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A151PDN7|A0A151PDN7_ALLMI,52.983,419,184,8,8,420,11,422,3.78e-144,426,A0A151PDN7,Vasoactive intestinal polypeptide receptor 1 isoform B OS=Alligator mississippiensis OX=8496 GN=VIPR1 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A6I9P465|A0A6I9P465_9TELE,50.976,410,189,6,28,429,21,426,3.82e-144,426,A0A6I9P465,pituitary adenylate cyclase-activating polypeptide type I receptor isoform X4 OS=Notothenia coriiceps OX=8208 GN=adcyap1r1 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A151PE63|A0A151PE63_ALLMI,51.972,431,193,8,8,432,11,433,3.95e-144,426,A0A151PE63,Vasoactive intestinal polypeptide receptor 1 isoform C OS=Alligator mississippiensis OX=8496 GN=VIPR1 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A3Q3B4S1|A0A3Q3B4S1_KRYMA,51.313,419,183,7,31,435,29,440,4.16e-144,426,A0A3Q3B4S1,Pituitary adenylate cyclase-activating polypeptide type I receptor-like OS=Kryptolebias marmoratus OX=37003 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A1S3GRL9|A0A1S3GRL9_DIPOR,46.926,488,200,6,1,432,1,485,4.18e-144,427,A0A1S3GRL9,pituitary adenylate cyclase-activating polypeptide type I receptor isoform X1 OS=Dipodomys ordii OX=10020 GN=Adcyap1r1 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A674BST8|A0A674BST8_SALTR,52.475,404,170,4,51,435,34,434,4.29e-144,426,A0A674BST8,Pituitary adenylate cyclase-activating polypeptide type I receptor-like OS=Salmo trutta OX=8032 GN=LOC115158670 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A671XIF7|A0A671XIF7_SPAAU,53.046,394,169,5,55,435,25,415,4.61e-144,425,A0A671XIF7,Pituitary adenylate cyclase-activating polypeptide type I receptor-like OS=Sparus aurata OX=8175 GN=LOC115591282 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A3Q2VN13|A0A3Q2VN13_HAPBU,50.930,430,193,9,9,429,6,426,4.96e-144,426,A0A3Q2VN13,Pituitary adenylate cyclase-activating polypeptide type I receptor-like OS=Haplochromis burtoni OX=8153 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A669D036|A0A669D036_ORENI,52.217,406,172,4,52,438,39,441,5.00e-144,426,A0A669D036,Adenylate cyclase activating polypeptide 1a (pituitary) receptor type I OS=Oreochromis niloticus OX=8128 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A7N6FAI6|A0A7N6FAI6_ANATE,50.000,424,200,5,20,435,20,439,5.00e-144,426,A0A7N6FAI6,Adenylate cyclase activating polypeptide 1b (pituitary) receptor type I OS=Anabas testudineus OX=64144 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A452DSX2|A0A452DSX2_CAPHI,49.433,441,184,6,21,429,38,471,5.02e-144,427,A0A452DSX2,ADCYAP receptor type I OS=Capra hircus OX=9925 GN=ADCYAP1R1 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A667YW75|A0A667YW75_9TELE,51.707,410,182,6,28,429,5,406,5.30e-144,425,A0A667YW75,Adenylate cyclase activating polypeptide 1a (pituitary) receptor type I OS=Myripristis murdjan OX=586833 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A2K6FND6|A0A2K6FND6_PROCO,49.772,438,189,5,20,429,20,454,5.74e-144,426,A0A2K6FND6,ADCYAP receptor type I OS=Propithecus coquereli OX=379532 GN=ADCYAP1R1 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A6Q2X7U0|A0A6Q2X7U0_ESOLU,53.218,404,167,5,51,435,57,457,6.80e-144,426,A0A6Q2X7U0,Pituitary adenylate cyclase-activating polypeptide type I receptor OS=Esox lucius OX=8010 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A7N6B386|A0A7N6B386_ANATE,50.602,415,191,5,31,435,26,436,7.14e-144,425,A0A7N6B386,Adenylate cyclase activating polypeptide 1b (pituitary) receptor type I OS=Anabas testudineus OX=64144 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A3P8UB88|A0A3P8UB88_AMPPE,54.427,384,166,5,51,429,37,416,7.40e-144,425,A0A3P8UB88,Adenylate cyclase activating polypeptide 1a (pituitary) receptor type I OS=Amphiprion percula OX=161767 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A6P8WQH1|A0A6P8WQH1_GYMAC,50.976,410,189,6,28,429,21,426,7.41e-144,425,A0A6P8WQH1,pituitary adenylate cyclase-activating polypeptide type I receptor-like isoform X4 OS=Gymnodraco acuticeps OX=8218 GN=LOC117557872 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A4W6BQ53|A0A4W6BQ53_LATCA,52.475,404,180,6,31,429,21,417,7.68e-144,425,A0A4W6BQ53,Adenylate cyclase activating polypeptide 1a (pituitary) receptor type I OS=Lates calcarifer OX=8187 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A4W4FFT7|A0A4W4FFT7_ELEEL,51.365,403,179,6,43,435,11,406,7.69e-144,424,A0A4W4FFT7,Uncharacterized protein OS=Electrophorus electricus OX=8005 GN=LOC113586160 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A3Q4MIK5|A0A3Q4MIK5_NEOBR,51.306,421,185,9,23,429,8,422,7.72e-144,425,A0A3Q4MIK5,Pituitary adenylate cyclase-activating polypeptide type I receptor-like OS=Neolamprologus brichardi OX=32507 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A151PDB4|A0A151PDB4_ALLMI,52.983,419,183,8,8,420,11,421,8.01e-144,425,A0A151PDB4,Vasoactive intestinal polypeptide receptor 1 isoform A OS=Alligator mississippiensis OX=8496 GN=VIPR1 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A667YW72|A0A667YW72_9TELE,51.707,410,186,6,28,429,24,429,8.02e-144,425,A0A667YW72,Adenylate cyclase activating polypeptide 1a (pituitary) receptor type I OS=Myripristis murdjan OX=586833 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A226P6K7|A0A226P6K7_COLVI,51.157,432,180,7,16,420,18,445,8.05e-144,426,A0A226P6K7,Uncharacterized protein OS=Colinus virginianus OX=9014 GN=H355_002723 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A3Q3FQQ0|A0A3Q3FQQ0_9LABR,52.405,395,175,4,51,435,16,407,8.22e-144,424,A0A3Q3FQQ0,Pituitary adenylate cyclase-activating polypeptide type I receptor-like OS=Labrus bergylta OX=56723 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A4W6BLC2|A0A4W6BLC2_LATCA,53.333,390,173,5,45,429,2,387,8.35e-144,424,A0A4W6BLC2,Adenylate cyclase activating polypeptide 1a (pituitary) receptor type I OS=Lates calcarifer OX=8187 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A7N9B089|A0A7N9B089_9TELE,54.688,384,164,5,51,429,35,413,9.41e-144,424,A0A7N9B089,Pituitary adenylate cyclase-activating polypeptide type I receptor-like OS=Mastacembelus armatus OX=205130 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A3Q2C7F1|A0A3Q2C7F1_CYPVA,50.985,406,189,5,31,429,40,442,1.11e-143,425,A0A3Q2C7F1,Pituitary adenylate cyclase-activating polypeptide type I receptor-like OS=Cyprinodon variegatus OX=28743 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A7N6BNX7|A0A7N6BNX7_ANATE,59.079,391,124,8,51,438,23,380,1.27e-143,422,A0A7N6BNX7,Uncharacterized protein OS=Anabas testudineus OX=64144 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A7N6BH21|A0A7N6BH21_ANATE,50.602,415,191,5,31,435,31,441,1.32e-143,424,A0A7N6BH21,Adenylate cyclase activating polypeptide 1b (pituitary) receptor type I OS=Anabas testudineus OX=64144 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A3Q1IJ27|A0A3Q1IJ27_ANATE,56.731,416,138,10,24,438,23,397,1.33e-143,423,A0A3Q1IJ27,Uncharacterized protein OS=Anabas testudineus OX=64144 PE=4 SV=2
sp|P41587|VIPR2_HUMAN,tr|A0A6P7M8C7|A0A6P7M8C7_BETSP,50.966,414,191,5,31,435,52,462,1.45e-143,425,A0A6P7M8C7,pituitary adenylate cyclase-activating polypeptide type I receptor-like isoform X2 OS=Betta splendens OX=158456 GN=LOC114853413 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|F6UWK2|F6UWK2_HORSE,50.231,432,179,6,31,429,27,455,1.60e-143,425,F6UWK2,ADCYAP receptor type I OS=Equus caballus OX=9796 GN=ADCYAP1R1 PE=4 SV=3
sp|P41587|VIPR2_HUMAN,tr|A0A3Q1HCB4|A0A3Q1HCB4_ANATE,51.111,405,191,4,31,429,31,434,1.62e-143,424,A0A3Q1HCB4,Adenylate cyclase activating polypeptide 1b (pituitary) receptor type I OS=Anabas testudineus OX=64144 PE=4 SV=2
sp|P41587|VIPR2_HUMAN,tr|A0A671XDY9|A0A671XDY9_SPAAU,51.843,407,167,5,55,435,24,427,2.32e-143,423,A0A671XDY9,Pituitary adenylate cyclase-activating polypeptide type I receptor-like OS=Sparus aurata OX=8175 GN=LOC115591282 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A3Q1M8B2|A0A3Q1M8B2_BOVIN,52.217,406,155,6,19,392,36,434,2.47e-143,425,A0A3Q1M8B2,Pituitary adenylate cyclase-activating polypeptide type I receptor OS=Bos taurus OX=9913 GN=ADCYAP1R1 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A674BU56|A0A674BU56_SALTR,52.750,400,171,4,51,435,28,424,2.48e-143,423,A0A674BU56,Pituitary adenylate cyclase-activating polypeptide type I receptor-like OS=Salmo trutta OX=8032 GN=LOC115158670 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A663M953|A0A663M953_ATHCN,49.011,455,186,6,18,429,33,484,3.37e-143,426,A0A663M953,ADCYAP receptor type I OS=Athene cunicularia OX=194338 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A4Z2HF54|A0A4Z2HF54_9TELE,51.015,394,185,3,41,429,2,392,3.41e-143,422,A0A4Z2HF54,Pituitary adenylate cyclase-activating polypeptide type I receptor OS=Liparis tanakae OX=230148 GN=EYF80_025858 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A1B8YA01|A0A1B8YA01_XENTR,47.884,449,198,6,10,429,10,451,3.89e-143,424,A0A1B8YA01,Adenylate cyclase-activating polypeptide 1 (pituitary) receptor type I OS=Xenopus tropicalis OX=8364 GN=chadl PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A665WGN8|A0A665WGN8_ECHNA,51.463,410,188,5,28,429,58,464,3.96e-143,425,A0A665WGN8,Adenylate cyclase activating polypeptide 1a (pituitary) receptor type I OS=Echeneis naucrates OX=173247 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A3Q3FN67|A0A3Q3FN67_9LABR,50.816,429,196,8,9,429,5,426,3.97e-143,423,A0A3Q3FN67,Pituitary adenylate cyclase-activating polypeptide type I receptor-like OS=Labrus bergylta OX=56723 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A674IRT4|A0A674IRT4_TERCA,55.388,399,163,7,29,420,2,392,4.30e-143,422,A0A674IRT4,Vasoactive intestinal peptide receptor 1 OS=Terrapene carolina triunguis OX=2587831 GN=VIPR1 PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A669FCC6|A0A669FCC6_ORENI,51.825,411,183,8,28,429,21,425,4.37e-143,423,A0A669FCC6,Uncharacterized protein OS=Oreochromis niloticus OX=8128 GN=LOC100710985 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,sp|Q91085|VIPR_MELGA,54.156,397,172,6,29,420,42,433,5.61e-143,423,Q91085,Vasoactive intestinal polypeptide receptor OS=Meleagris gallopavo OX=9103 GN=VIPR1 PE=2 SV=2
sp|P41587|VIPR2_HUMAN,tr|A0A7N5KFK5|A0A7N5KFK5_AILME,46.985,481,198,7,1,429,1,476,5.87e-143,424,A0A7N5KFK5,ADCYAP receptor type I OS=Ailuropoda melanoleuca OX=9646 GN=ADCYAP1R1 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A3Q1EUV0|A0A3Q1EUV0_9TELE,51.699,412,172,6,36,429,24,426,6.89e-143,422,A0A3Q1EUV0,Pituitary adenylate cyclase-activating polypeptide type I receptor-like OS=Acanthochromis polyacanthus OX=80966 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A4X2LNQ7|A0A4X2LNQ7_VOMUR,50.708,424,181,6,31,429,17,437,8.00e-143,423,A0A4X2LNQ7,ADCYAP receptor type I OS=Vombatus ursinus OX=29139 GN=ADCYAP1R1 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A3P8UGF5|A0A3P8UGF5_AMPPE,54.286,385,167,5,50,429,40,420,9.43e-143,422,A0A3P8UGF5,Adenylate cyclase activating polypeptide 1a (pituitary) receptor type I OS=Amphiprion percula OX=161767 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A1L8FQG9|A0A1L8FQG9_XENLA,53.555,422,186,7,2,420,6,420,9.58e-143,422,A0A1L8FQG9,Uncharacterized protein OS=Xenopus laevis OX=8355 GN=vipr1.S PE=3 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A452IRL7|A0A452IRL7_9SAUR,47.269,476,201,6,1,429,1,473,1.06e-142,424,A0A452IRL7,ADCYAP receptor type I OS=Gopherus agassizii OX=38772 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A1U8D7Y1|A0A1U8D7Y1_ALLSI,51.781,421,187,7,29,438,2,417,1.10e-142,421,A0A1U8D7Y1,vasoactive intestinal polypeptide receptor 1 isoform X1 OS=Alligator sinensis OX=38654 GN=VIPR1 PE=3 SV=2
sp|P41587|VIPR2_HUMAN,tr|H2SCN9|H2SCN9_TAKRU,50.478,418,190,6,31,435,28,441,1.10e-142,422,H2SCN9,Uncharacterized protein OS=Takifugu rubripes OX=31033 GN=pacap1b PE=4 SV=2
sp|P41587|VIPR2_HUMAN,tr|A0A6Q2ZN91|A0A6Q2ZN91_ESOLU,50.346,433,184,7,31,435,17,446,1.11e-142,422,A0A6Q2ZN91,Pituitary adenylate cyclase-activating polypeptide type I receptor OS=Esox lucius OX=8010 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A3Q4HCF2|A0A3Q4HCF2_NEOBR,57.216,388,130,7,51,438,10,361,1.13e-142,419,A0A3Q4HCF2,Vasoactive intestinal polypeptide receptor 2-like OS=Neolamprologus brichardi OX=32507 GN=VIPR2 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A4W6BSK9|A0A4W6BSK9_LATCA,53.766,385,169,5,50,429,16,396,1.14e-142,421,A0A4W6BSK9,Adenylate cyclase activating polypeptide 1a (pituitary) receptor type I OS=Lates calcarifer OX=8187 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A4W6BSY4|A0A4W6BSY4_LATCA,55.645,372,154,5,28,392,99,466,1.24e-142,425,A0A4W6BSY4,Adenylate cyclase activating polypeptide 1a (pituitary) receptor type I OS=Lates calcarifer OX=8187 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A669CLR1|A0A669CLR1_ORENI,48.655,446,188,6,31,438,30,472,1.26e-142,423,A0A669CLR1,Adenylate cyclase activating polypeptide 1a (pituitary) receptor type I OS=Oreochromis niloticus OX=8128 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A6J0V2E2|A0A6J0V2E2_9SAUR,47.323,467,192,10,9,429,1,459,1.31e-142,423,A0A6J0V2E2,pituitary adenylate cyclase-activating polypeptide type I receptor OS=Pogona vitticeps OX=103695 GN=ADCYAP1R1 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A6J2RDS9|A0A6J2RDS9_COTGO,50.577,433,190,9,9,429,5,425,1.31e-142,422,A0A6J2RDS9,pituitary adenylate cyclase-activating polypeptide type I receptor-like isoform X4 OS=Cottoperca gobio OX=56716 GN=LOC115022212 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A671WE93|A0A671WE93_SPAAU,56.764,377,158,4,65,438,27,401,1.76e-142,420,A0A671WE93,Vasoactive intestinal polypeptide receptor 2-like OS=Sparus aurata OX=8175 GN=LOC115569556 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A674BQL5|A0A674BQL5_SALTR,53.401,397,164,5,51,429,23,416,2.06e-142,421,A0A674BQL5,Pituitary adenylate cyclase-activating polypeptide type I receptor-like OS=Salmo trutta OX=8032 GN=LOC115158670 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A671G5V8|A0A671G5V8_RHIFE,46.804,485,199,6,1,429,1,482,2.14e-142,423,A0A671G5V8,ADCYAP receptor type I OS=Rhinolophus ferrumequinum OX=59479 GN=ADCYAP1R1 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A7N6BXH6|A0A7N6BXH6_ANATE,56.145,415,143,8,24,438,23,398,2.40e-142,419,A0A7N6BXH6,Uncharacterized protein OS=Anabas testudineus OX=64144 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A452CBJ9|A0A452CBJ9_BALAS,47.817,458,183,7,21,429,21,471,2.84e-142,422,A0A452CBJ9,pituitary adenylate cyclase-activating polypeptide type I receptor isoform X4 OS=Balaenoptera acutorostrata scammoni OX=310752 GN=ADCYAP1R1 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A670YX30|A0A670YX30_PSETE,48.018,454,184,9,20,429,4,449,3.04e-142,422,A0A670YX30,ADCYAP receptor type I OS=Pseudonaja textilis OX=8673 GN=ADCYAP1R1 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A6I9LR37|A0A6I9LR37_PERMB,46.531,490,203,6,2,435,7,493,3.13e-142,423,A0A6I9LR37,pituitary adenylate cyclase-activating polypeptide type I receptor isoform X2 OS=Peromyscus maniculatus bairdii OX=230844 GN=Adcyap1r1 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A6J0DZW2|A0A6J0DZW2_PERMB,46.436,491,203,6,2,435,7,494,3.45e-142,423,A0A6J0DZW2,pituitary adenylate cyclase-activating polypeptide type I receptor isoform X1 OS=Peromyscus maniculatus bairdii OX=230844 GN=Adcyap1r1 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A2K6SQL1|A0A2K6SQL1_SAIBB,47.071,478,191,8,5,429,1,469,3.72e-142,422,A0A2K6SQL1,ADCYAP receptor type I OS=Saimiri boliviensis boliviensis OX=39432 GN=ADCYAP1R1 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A493SXZ1|A0A493SXZ1_ANAPP,47.107,484,186,7,9,429,9,485,3.73e-142,423,A0A493SXZ1,ADCYAP receptor type I OS=Anas platyrhynchos platyrhynchos OX=8840 GN=ADCYAP1R1 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A669B1J5|A0A669B1J5_ORENI,51.084,415,172,5,52,438,12,423,4.22e-142,420,A0A669B1J5,Adenylate cyclase activating polypeptide 1a (pituitary) receptor type I OS=Oreochromis niloticus OX=8128 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A667YCB7|A0A667YCB7_9TELE,53.247,385,171,5,50,429,24,404,4.45e-142,420,A0A667YCB7,Adenylate cyclase activating polypeptide 1a (pituitary) receptor type I OS=Myripristis murdjan OX=586833 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A6G0HKQ5|A0A6G0HKQ5_LARCR,53.118,433,199,3,9,438,11,442,4.49e-142,421,A0A6G0HKQ5,Vasoactive intestinal polypeptide receptor 2 OS=Larimichthys crocea OX=215358 GN=D5F01_LYC21765 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A2I4CWH9|A0A2I4CWH9_9TELE,53.264,383,171,3,52,429,13,392,5.64e-142,419,A0A2I4CWH9,pituitary adenylate cyclase-activating polypeptide type I receptor-like OS=Austrofundulus limnaeus OX=52670 GN=LOC106532758 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A4W4DWX6|A0A4W4DWX6_ELEEL,52.463,406,182,7,31,429,28,429,5.92e-142,421,A0A4W4DWX6,Uncharacterized protein OS=Electrophorus electricus OX=8005 GN=LOC113584361 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A5C6NV19|A0A5C6NV19_9TELE,52.194,433,203,3,9,438,13,444,5.97e-142,420,A0A5C6NV19,Vasoactive intestinal polypeptide receptor 2 OS=Takifugu flavidus OX=433684 GN=D4764_17G0001510 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A1U8D590|A0A1U8D590_ALLSI,51.905,420,187,7,29,438,2,416,6.27e-142,419,A0A1U8D590,vasoactive intestinal polypeptide receptor 1 isoform X2 OS=Alligator sinensis OX=38654 GN=VIPR1 PE=3 SV=2
sp|P41587|VIPR2_HUMAN,tr|A0A7N6BUH5|A0A7N6BUH5_ANATE,51.899,395,180,4,47,435,13,403,6.46e-142,419,A0A7N6BUH5,Adenylate cyclase activating polypeptide 1b (pituitary) receptor type I OS=Anabas testudineus OX=64144 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A4W4DX80|A0A4W4DX80_ELEEL,52.463,406,182,7,31,429,30,431,6.61e-142,420,A0A4W4DX80,Uncharacterized protein OS=Electrophorus electricus OX=8005 GN=LOC113584361 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A6P7K2Z6|A0A6P7K2Z6_9TELE,51.100,409,189,6,28,429,27,431,6.75e-142,420,A0A6P7K2Z6,pituitary adenylate cyclase-activating polypeptide type I receptor-like isoform X2 OS=Parambassis ranga OX=210632 GN=LOC114450003 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A6P3W7L5|A0A6P3W7L5_CLUHA,49.431,439,207,7,1,429,1,434,6.84e-142,421,A0A6P3W7L5,pituitary adenylate cyclase-activating polypeptide type I receptor isoform X2 OS=Clupea harengus OX=7950 GN=adcyap1r1 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A6J3CJV1|A0A6J3CJV1_AYTFU,46.998,483,187,7,9,429,9,484,7.24e-142,422,A0A6J3CJV1,pituitary adenylate cyclase-activating polypeptide type I receptor isoform X3 OS=Aythya fuligula OX=219594 GN=ADCYAP1R1 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A2K5U6R8|A0A2K5U6R8_MACFA,50.114,437,202,7,1,429,1,429,7.66e-142,420,A0A2K5U6R8,ADCYAP receptor type I OS=Macaca fascicularis OX=9541 GN=ADCYAP1R1 PE=4 SV=2
sp|P41587|VIPR2_HUMAN,tr|A0A498MWY4|A0A498MWY4_LABRO,52.826,407,179,7,31,429,13,414,8.65e-142,419,A0A498MWY4,Pituitary adenylate cyclase-activating polypeptide type I receptor-like isoform X2 OS=Labeo rohita OX=84645 GN=ROHU_021635 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A6P6E0K7|A0A6P6E0K7_OCTDE,47.797,454,191,7,21,435,21,467,9.17e-142,421,A0A6P6E0K7,pituitary adenylate cyclase-activating polypeptide type I receptor isoform X3 OS=Octodon degus OX=10160 GN=Adcyap1r1 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A665WGP1|A0A665WGP1_ECHNA,53.786,383,166,5,52,429,23,399,9.19e-142,419,A0A665WGP1,Adenylate cyclase activating polypeptide 1a (pituitary) receptor type I OS=Echeneis naucrates OX=173247 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A4W4DVF4|A0A4W4DVF4_ELEEL,52.463,406,182,7,31,429,49,450,9.35e-142,421,A0A4W4DVF4,Uncharacterized protein OS=Electrophorus electricus OX=8005 GN=LOC113584361 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A6P6E0F1|A0A6P6E0F1_OCTDE,47.797,454,191,7,21,435,21,467,9.37e-142,421,A0A6P6E0F1,pituitary adenylate cyclase-activating polypeptide type I receptor isoform X2 OS=Octodon degus OX=10160 GN=Adcyap1r1 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A6J3CN03|A0A6J3CN03_AYTFU,46.901,484,187,7,9,429,9,485,9.60e-142,422,A0A6J3CN03,pituitary adenylate cyclase-activating polypeptide type I receptor isoform X2 OS=Aythya fuligula OX=219594 GN=ADCYAP1R1 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A3Q1HDR7|A0A3Q1HDR7_ANATE,50.488,410,191,6,28,429,19,424,9.73e-142,420,A0A3Q1HDR7,Pituitary adenylate cyclase-activating polypeptide type I receptor-like OS=Anabas testudineus OX=64144 PE=4 SV=2
sp|P41587|VIPR2_HUMAN,tr|A0A1V4KLG2|A0A1V4KLG2_PATFA,47.368,475,180,7,18,429,2,469,1.17e-141,421,A0A1V4KLG2,Pituitary adenylate cyclase-activating polypeptide type I receptor isoform B OS=Patagioenas fasciata monilis OX=372326 GN=ADCYAP1R1 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A2I0MRD5|A0A2I0MRD5_COLLI,47.368,475,180,7,18,429,2,469,1.17e-141,421,A0A2I0MRD5,Adenylate cyclase activating polypeptide 1 (Pituitary) receptor type I OS=Columba livia OX=8932 GN=ADCYAP1R1 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A3B1IHU2|A0A3B1IHU2_ASTMX,54.545,385,161,7,14,392,54,430,1.32e-141,421,A0A3B1IHU2,Adenylate cyclase activating polypeptide 1a (pituitary) receptor type I OS=Astyanax mexicanus OX=7994 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A3B1JYQ0|A0A3B1JYQ0_ASTMX,55.978,368,152,6,31,392,32,395,1.39e-141,420,A0A3B1JYQ0,Adenylate cyclase activating polypeptide 1a (pituitary) receptor type I OS=Astyanax mexicanus OX=7994 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A3B1IQW9|A0A3B1IQW9_ASTMX,52.463,406,182,7,31,429,23,424,1.41e-141,419,A0A3B1IQW9,Adenylate cyclase activating polypeptide 1a (pituitary) receptor type I OS=Astyanax mexicanus OX=7994 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A2K6M074|A0A2K6M074_RHIBE,48.156,461,179,7,22,429,22,475,1.45e-141,421,A0A2K6M074,Uncharacterized protein OS=Rhinopithecus bieti OX=61621 GN=ADCYAP1R1 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A673UK72|A0A673UK72_SURSU,45.808,489,198,7,1,429,1,482,1.53e-141,421,A0A673UK72,ADCYAP receptor type I OS=Suricata suricatta OX=37032 GN=ADCYAP1R1 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A7N5ZU04|A0A7N5ZU04_ANATE,50.488,410,191,6,28,429,21,426,1.64e-141,419,A0A7N5ZU04,Pituitary adenylate cyclase-activating polypeptide type I receptor-like OS=Anabas testudineus OX=64144 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A4W4FGI0|A0A4W4FGI0_ELEEL,52.163,393,169,6,55,435,38,423,1.65e-141,419,A0A4W4FGI0,Uncharacterized protein OS=Electrophorus electricus OX=8005 GN=LOC113586160 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A3B1JMS5|A0A3B1JMS5_ASTMX,55.978,368,152,6,31,392,21,384,1.66e-141,419,A0A3B1JMS5,Adenylate cyclase activating polypeptide 1a (pituitary) receptor type I OS=Astyanax mexicanus OX=7994 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A670YWM0|A0A670YWM0_PSETE,48.026,456,183,9,20,429,18,465,1.78e-141,420,A0A670YWM0,ADCYAP receptor type I OS=Pseudonaja textilis OX=8673 GN=ADCYAP1R1 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A3Q2UHX2|A0A3Q2UHX2_CHICK,46.901,484,187,7,9,429,9,485,1.82e-141,421,A0A3Q2UHX2,Uncharacterized protein OS=Gallus gallus OX=9031 GN=ADCYAP1R1 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A2I3LT46|A0A2I3LT46_PAPAN,46.835,474,200,7,1,429,1,467,2.10e-141,420,A0A2I3LT46,ADCYAP receptor type I OS=Papio anubis OX=9555 GN=ADCYAP1R1 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A2R8MYS9|A0A2R8MYS9_CALJA,49.217,447,181,7,22,429,92,531,2.14e-141,422,A0A2R8MYS9,Uncharacterized protein OS=Callithrix jacchus OX=9483 GN=ADCYAP1R1 PE=4 SV=1
sp|P41587|VIPR2_HUMAN,tr|A0A667YG44|A0A667YG44_9TELE,53.385,384,170,5,51,429,55,434,2.19e-141,419,A0A667YG44,Adenylate cyclase activating polypeptide 1a (pituitary) receptor type I OS=Myripristis murdjan OX=586833 PE=4 SV=1
